1. Introduction {#sec1}
===============

Pathogens are infectious agents that cause disease. They include microorganisms, such as fungi, protozoans, and bacteria, and molecular-scale infectious agents, including viruses and prions. Foodborne, waterborne, and airborne pathogens enter the body through various modes of infection and are responsible for over 15 million deaths annually worldwide ([@bib72]). Some of the most common pathogens include viruses, such as norovirus and influenza virus, and bacteria, such as *E. coli* and *S. aureus*. Pathogens vary in many regards, such as virulence, contagiousness, mode of transmission, and infectious dose. For example, the world is currently facing a global pandemic associated with the COVID-19 virus, for which virulence and infectious dose data are still emerging. Techniques for sensitive and rapid detection of pathogens in complex matrices, such as body fluids and aerosols, and on surfaces are critical to the treatment of infectious diseases and controlling the spread of disease.

The techniques used to identify and quantify pathogens can be broadly distinguished as immunoassays or DNA-based assays. The use of immunoassays versus DNA-based assays depends on various factors, including the stage of an infection and the availability of antibodies and DNA sequence data, such as viral DNA, toxin-producing genes, as well as species- and strain-selective genes. Immunoassays are ubiquitous across medical diagnostics and food safety applications. Pathogens can be identified through the presence of generated antibodies in an organism, which may be present both during and after an infection (*i.e.,* after the pathogen is no longer present). In such assays, both the biorecognition element and the target are antibodies. If antibodies are available for the pathogen (*e.g.,* anti-*E. coli* O157:H7), one can also directly detect the pathogen using immunoassays. The ability to indirectly and directly detect pathogens via generated antibodies and pathogen epitopes, respectively, makes immunoassays flexible techniques for pathogen detection. In cases of limited antibody availability, need for highly sensitive results, or infections that do *not* generate a significant level of antibody production in the organism although the pathogen is present, DNA-based assays are commonly employed. DNA-based assays require the pathogen to be present in the sample or to have been recently present. In addition to detection of pathogens using antibodies or toxin-producing genes, pathogens can also be detected based on their expression of toxins. Thus, targets associated with pathogen detection include toxins, nucleic acids, viruses, cells, and oocysts. As a result, biorecognition elements widely vary, including antibodies, aptamers, and imprinted polymers. Several comprehensive reviews have been written on pathogen detection using high-throughput, well plate-based bioanalytical techniques ([@bib6]; [@bib154]; [@bib337]), such as enzyme-linked immunosorbent assay (ELISA) ([@bib152]) and polymerase chain reaction (PCR) ([@bib140]; [@bib184]), which remain the gold standards for pathogen detection. Few reviews, however, have focused on emerging label-free biosensors for pathogen detection, which provide useful characteristics for applications in process monitoring (*e.g.,* of biomanufacturing processes), environmental monitoring, and precision agriculture.

Bioanalytical techniques utilize a selective biorecognition element, often called a molecular probe, in combination with an analytical system, such as a plate reader or PCR analyzer, to quantify one or more components of a sample. While capable of being highly sensitive and robust, they are destructive testing methods and require the addition of reagents to the sample and extensive sample preparation steps, which increase the time-to-results (TTR). Bioanalytical techniques, such as PCR, may also encounter inhibition effects caused by background species in the sample ([@bib134]; [@bib245]; [@bib258]), which introduce measurement bias and increase measurement uncertainty ([@bib55]; [@bib257]). Considering such limitations of traditional plate-based bioanalytical techniques and the need for real-time continuous monitoring capabilities among various applications, there is a need to examine alternative bioanalytical techniques.

Over the past twenty-five years, biosensors have emerged to complement PCR and ELISA for pathogen detection. Biosensors are based on the direct integration of a selective biorecognition element and a sensitive transducer element and provide complementary platforms to PCR and ELISA for pathogen identification and quantification. According to the International Union of Pure and Applied Chemistry (IUPAC), a biosensor must contain a biorecognition element in direct spatial contact with a transduction element ([@bib272]). In addition, a biosensor should provide quantitative or semi-quantitative analytical information and measurement *without* the requirement of additional processing steps or reagents. While a biosensor should also be a self-contained, integrated device, the measurement approach can vary from droplet formats to continuous flow formats that require associated fluid handling systems. Biosensors have achieved sensitive and selective real-time detection of pathogens in various environments *without* the need for sample preparation. For example, biosensors have enabled the detection of an abundance of pathogens in various matrices and environments, including foods, body fluids, and object surfaces. In addition to sample preparation-free protocols, biosensors are compatible with label-free protocols ([@bib59]; [@bib227]; [@bib239]; [@bib283]). Labels, often referred to as reporters, are molecular species, such as organic dyes or quantum dots ([@bib232]), that are attached to the target, either directly or through a biorecognition element, using a series of sample preparation steps or secondary binding steps to facilitate detection through the properties of the label. Thus, label-free biosensors avoid the use of a reporter species to detect the target species ([@bib57]; [@bib268]). Label-free assays often have fewer sample preparation steps due to the elimination of procedures associated with target labeling and lower cost than label-based assays, which are important considerations for applications in which preparation facilities or trained personnel are either limited or unavailable ([@bib57]; [@bib268]).

While various types of transducers have been investigated for pathogen biosensing ([@bib154]; [@bib261]; [@bib324]), including mechanical and optical transducers, such as cantilever biosensors or surface plasmon resonance (SPR)-based biosensors, electrochemical biosensors have been extensively applied to pathogen detection ([@bib82]; [@bib217]; [@bib240]). Electrochemical biosensors for pathogen detection utilize conducting and semiconducting materials as the transducer, which is commonly referred to as an electrode. The chemical energy associated with binding between target pathogens and electrode-immobilized biorecognition elements is converted into electrical energy through an electrochemical method that involves the electrode and a pathogen-containing electrolyte solution. To date, electrochemical biosensors have enabled sample preparation-free detection of pathogens in various matrices, *in situ* detection of pathogens on surfaces, rapid pathogen detection using low-cost platforms, multiplexed detection of pathogens in practical matrices, and detection of pathogens via wireless actuation and data acquisition formats. As a result, electrochemical biosensors for pathogen detection have been widely examined for food and water safety, medical diagnostic, environmental monitoring, and bio-threat applications ([@bib9]; [@bib70]; [@bib82]; [@bib86]; [@bib196]; [@bib198]; [@bib229]).

Here, we critically review electrochemical biosensors for pathogen detection. To gain insight into the trajectory of the field, electrochemical biosensors for pathogen detection reported since 2005 are critically reviewed and classified with respect to IUPAC-recommended definitions and classifications ([@bib272]). Applications of electrochemical biosensors for pathogen detection are critically reviewed with respect to the target pathogen, sample matrix, biosensor design, fabrication method, measurement format, and biosensor performance. We also discuss future directions of electrochemical biosensors for pathogen detection, which includes a discussion of present technological and methodological challenges and emerging application areas.

2. Electrochemical biosensor designs for pathogen detection {#sec2}
===========================================================

A chemical sensor is a device that transforms chemical information, such as the concentration of a specific sample component or total compositional analysis into an analytically useful signal ([@bib272]). The electrochemical method utilized is a distinguishing aspect of an electrochemical biosensor. In addition to the electrochemical method, the sample handling approach and sensor signal readout format also provide distinguishing aspects of a biosensor-based approach for pathogen detection. Thus, we review electrochemical biosensors for pathogen detection using a framework built upon transducer elements, biorecognition elements, and measurement formats. An overview of electrochemical biosensors for pathogen detection is provided in [Fig. 1](#fig1){ref-type="fig"} . As shown in [Fig. 2](#fig2){ref-type="fig"} a, while the detection of bacterial pathogens remains an area of focus, the detection of viral pathogens and protozoa is an emerging area. As shown in [Fig. 2](#fig2){ref-type="fig"}b, studies have focused on pathogen detection in various matrices. We next discuss the transduction elements, biorecognition elements, and measurement formats associated with electrochemical biosensors for pathogen detection.Fig. 1Components and measurement formats associated with electrochemical biosensors for pathogen detection.Fig. 1Fig. 2**a**) Trend in pathogens detected by electrochemical biosensors since 2005 based on the data shown in [Table 1](#tbl1){ref-type="table"}, [Table 2](#tbl2){ref-type="table"}. **b**) Common matrices associated with the various pathogen detection applications.Fig. 2

2.1. Transduction elements {#sec2.1}
--------------------------

The transduction element of an electrochemical biosensor is an electrochemical cell where the main component is commonly a working electrode. A three electrode format (working, auxiliary, and reference) is commonly employed in a potentiostatic system, while a two electrode format (working and auxiliary) is often used for conductometry and electrochemical impedance spectroscopy (EIS). Electrodes can be fabricated from multiple materials and using various manufacturing processes. An electrode is an electronic conductor through which charge is transported by the movement of electrons and holes ([@bib17]). Electrodes are thus fabricated from conducting and semiconducting materials, including metals, such as gold (Au), and nonmetals, such as carbon. Manufacturing processes can be used to fabricate electrodes of various sizes, including bulk structures (greater than 1 mm) and micro- and nano-structures. As a result, electrodes can be classified by type and form of material, manufacturing process, and design. Electrode designs can be classified by form factor, which includes planar, wire, nanostructured, or array-based. The material, fabrication approach, and design affect the electrode\'s structure and properties, which ultimately determine the biosensor\'s performance, including sensitivity, selectivity, limit of detection (LOD), and dynamic range. They also influence the biosensor\'s cost, manufacturability, disposability, and measurement capabilities.

### 2.1.1. Metal electrodes {#sec2.1.1}

Metal electrodes, such as Au and platinum (Pt), have been commonly used for pathogen detection. Thick metal electrodes are commonly fabricated from bulk structures via cutting processes. Thin-film metal electrodes are often fabricated by deposition of metals on insulating substrates through traditional microfabrication approaches, including physical vapor deposition ([@bib108]) and screen printing ([@bib269]). Resultant conductive components are often embedded in insulating polymer or ceramic substrates, including Teflon, polyetherkeytone (PEK), and glass, to complete fabrication of the transducer element. While not yet applied to pathogen detection applications, three-dimensional (3D) printing processes, including inkjet printing ([@bib28]; [@bib191]; [@bib215]), selective laser melting ([@bib8]; [@bib171]), and microextrusion printing ([@bib83]), have also been used for the fabrication of electrochemical sensors and electrodes using a variety of metals. As shown in [Table 1](#tbl1){ref-type="table"} , unstructured metal electrodes exhibit a range of detection limits. For example, the detection limits of electrochemical biosensors for bacteria that employ unstructured metal electrodes range from 1 to 10^4^ CFU/mL (see [Table 1](#tbl1){ref-type="table"}).Table 1Classification of label-free electrochemical biosensors for detection of pathogens in terms of: target, working electrode, biorecognition element, electrochemical method, limit of detection, and electrochemical probe. *Abbreviations*: quartz crystal microbalance (QCM), electrochemical impedance spectroscopy (EIS), cyclic voltammetry (CV), plaque-forming unit (PFU), colony-forming unit (CFU), indium tin oxide (ITO), carbon nanotube (CNT), magnetic bead (MB), nanoparticle (NP), differential pulse voltammetry (DPV), square wave voltammetry (SWV), anodic stripping voltammetry (ASV), hemagglutination units (HAU), and median tissue culture infectious dose (TCID~50~).Table 1Target PathogenWorking ElectrodeBiorecognition ElementElectrochemical Method & ProbeLimit of DetectionReference*E. coli*Au interdigitated microelectrode arraypolyclonal anti-*E.coli*EIS10^4^ CFU/mL[@bib224]*E. coli*ITO electrodemonoclonal anti-*E. coli*CV, EIS; Fe(CN)~6~^3-/4-^4 × 10^3^ CFU/mL[@bib330]*E. coli*chromium interdigitated microelectrode arrayanti-*E. coli*EIS--[@bib267]*S. typhimurium*ITO interdigitated microelectrode arrayanti-*S. typhimurium*EIS10 CFU/mL[@bib318]*V. cholerae*carbon electrodepolyclonal anti-*V. cholerae*amperometry8 CFU/mL[@bib252]*E. coli*Pt wire electrodepolyclonal anti-*E. coli*potentiometry9 × 10^5^ CFU/mL[@bib30]*E. coli*Au microelectrodepolyclonal anti-*E.coli*EIS10 CFU/mL[@bib180]*L. monocytogenes*TiO~2~ nanowires on Au electrodemonoclonal anti-*L. monocytogenes*EIS470 CFU/mL[@bib294]*E. coli*Au electrodepolyclonal anti-*E. coli*CV, EIS; Fe(CN)~6~^3-/4-^50 CFU/mL[@bib88]*S. typhimurium*Au electrodepolyclonal anti-*S. typhimurium*EIS; Fe(CN)~6~^3-/4-^10 CFU/mL[@bib220]*S. typhimurium*Au microelectrodeanti-*S. typhimurium*EIS; Fe(CN)~6~^3-/4-^500 CFU/mL[@bib200]*E. coli*graphite interdigitated microelectrode array*E. coli*-specific bacteriophagesEIS10^4^ CFU/mL[@bib249]*S. typhimurium*Au electrodepolyclonal anti*-S. typhimurium*EIS100 CFU/mL[@bib187]*S. typhimurium*macroporous silicon electrodeanti-*S. typhimurium*EIS10^3^ CFU/mL[@bib60]West Nile virus (WNV)nanostructured alumina on Pt wire electrodemonoclonal anti-WNVAC voltammetry0.02 viruses/mL[@bib203]*S. typhimurium*Au electrodemonoclonal anti-*S. typhimurium*EIS; Fe(CN)~6~^3-/4-^100 CFU/mL[@bib147]*S. typhimurium*CNTs on carbon rod electrodeanti-*S. typhimurium* aptamerpotentiometry0.2 CFU/mL[@bib327]*E. coli*Au electrodeanti-*E. coli*CV, EIS; Fe(CN)~6~^3-/4-^3.3 CFU/mL[@bib77]*B. anthracis*Ag electrodemonoclonal and polyclonal anti-*B. anthracis*conductometry420 spores/mL[@bib207]*E. coli*polysilicon interdigitated microelectrode arraypolyclonal anti-*E. coli*EIS300 CFU/mL[@bib64]*E. coli*Au interdigitated microelectrode array*E. coli-*specific bacteriophagesEIS10^4^ CFU/mL[@bib193]*E. coli*CNTs on carbon rod electrodeanti-*E. coli* aptamerpotentiometry6 CFU/mL[@bib326]*Campylobacter jejuni*Fe~3~O~4~ nanoparticles on carbon electrodemonoclonal anti-Flagellin AEIS; Fe(CN)~6~^3-/4-^10^3^ CFU/mL[@bib115]marine pathogenic sulphate-reducing bacteria (SRB)AuNPs on nickel foam electrodeanti-SRBEIS21 CFU/mL[@bib291]*E. coli*Ag nanofiber array electrodemonoclonal and polyclonal anti*-E. coli*conductometry61 CFU/mL[@bib177]bovine viral diarrhea virus (BVDV)Ag nanofiber array electrodemonoclonal and polyclonal anti-BVDVconductometry103 CCID/mL[@bib177]*E. coli*Au interdigitated microelectrode arraymagainin I peptideEIS10^3^ CFU/mL[@bib186]*E. coli*Au rod electrodeconcanavalin A lectincapacitive12 CFU/mL[@bib124]rotavirusgraphene microelectrodemonoclonal anti-rotavirusCV10^3^ PFU/mL[@bib169]human influenza A virus H3N2Au electrodepolyclonal anti-H3N2EIS8 ng/mL[@bib105]*E. coli*Au microelectrodepolyclonal anti-*E. coli*capacitive, EIS, CV; Fe(CN)~6~^3-/4-^220 CFU/mL[@bib160]*Enterobacter cloacae*Au electrodeconcanavalin A lectin, ricinus communis agglutinin lectinCV, EIS; Fe(CN)~6~^3-/4-^1 × 10^3^ CFU/mL[@bib307]*E. coli*Au electrodeconcanavalin A lectin, ricinus communis agglutinin lectinCV, EIS; Fe(CN)~6~^3-/4-^100 CFU/mL[@bib307]*B. subtilis*Au electrodeconcanavalin A lectinCV, EIS; Fe(CN)~6~^3-/4-^1 × 10^4^ CFU/mL[@bib307]*E. coli*Pt wire electrodeanti-*E. coli*EIS100 CFU/mL[@bib271]*S. aureus*Pt wire electrodeanti-*S. aureus*EIS100 CFU/mL[@bib271]marine pathogenic sulphate-reducing bacteria (SRB)graphene/chitosan composite on carbon electrodeanti-SRBCV, EIS; Fe(CN)~6~^3-/4-^18 CFU/mL[@bib289]swine influenza virus (SIV) H1N1PDDA/CNT composite on Au microelectrodeanti-SIVconductometry180 TCID~50~/mL[@bib157]*E. coli*graphene microelectrodeanti-*E. coli*amperometry10 CFU/mL[@bib116]*E. coli*PEDOT:PSS electrodeanti-*E. coli*amperometry10^3^ CFU/mL[@bib106]dengue type 2 virus (DENV-2)nanostructured alumina on Pt wire electrodemonoclonal anti-DENV-2DPV;\
Ferrocene methanol1 PFU/mL[@bib48]DENV-2nanostructured alumina on Pt wire electrodemonoclonal anti-DENV-2CV, EIS; Ferrocene methanol1 PFU/mL[@bib204]human influenza A viruses H1N1 and H3N2silicon nanowire electrode arrayanti-H1N1, anti-H3N2conductometry2.9 × 10^4^ viruses/mL[@bib254]*E. coli*AuNP/Chitosan/CNT and SiO2/thionine NP composite on Au electrodemonoclonal anti-*E. coli*CV250 CFU/mL[@bib161]*E. coli*CNT/polyallylamine composite on graphite electrodemonoclonal anti-*E. coli*ASV800 cells/mL[@bib284]*Campylobacter*CNT/polyallylamine composite on graphite electrodemonoclonal anti-*Campylobacter*ASV400 cells/mL[@bib284]*S. typhimurium*CNT/polyallylamine composite on graphite electrodemonoclonal anti-*S. typhimurium*ASV400 cells/mL[@bib284]*S. aureus*CNT electrodeanti-*S. aureus* aptamerpotentiometry800 CFU/mL[@bib328]*E. coli*Au electrodemannose carbohydrate ligandEIS; Fe(CN)~6~^3-/4-^100 CFU/mL[@bib98]*S. aureus*graphene interdigitated microelectrode arrayodoranin-HP peptideconductometry1 × 10^4^ cells/mL[@bib185]*Helicobacter pylori*graphene interdigitated microelectrode arrayodoranin-HP peptideconductometry100 cells[@bib185]*L. innocua*Au electrode*L. innocua*-specific bacteriophageEIS; Fe(CN)~6~^3-/4-^1.1 × 10^4^ CFU/mL[@bib275]*E. coli*polyaniline on Au electrodemonoclonal anti-*E. coli*EIS100 CFU/mL[@bib52].*E. coli*Au interdigitated microelectrode arrayanti-*E. coli*EIS2.5 × 10^4^ CFU/mL[@bib71].*E. coli*ultra-nanocrystalline diamond microelectrode arrayanti-*E. coli*EIS; Fe(CN)~6~^3-/4-^1 × 10^3^ CFU/mL[@bib255].human influenza A virus H1N1Au microelectrodephenotype-specific sialic acid-galactose moietiesEIS; Fe(CN)~6~^3-/4-^--[@bib304]*E. coli*Au electrode*E. coli*-specific bacteriophagesEIS; Fe(CN)~6~^3-/4-^800 CFU/mL[@bib274]DENV-2, dengue virus 3 (DENV-3)Pt-coated nanostructured alumina membrane electrodemonoclonal anti-dengueEIS; Fe(CN)~6~^3-/4-^0.23 PFU/mL, 0.71 PFU/mL[@bib216]cucumber mosaic virus (CMV)polypyrrole nanoribbons on Au microelectrode arraypolyclonal anti-CMVamperometry10 ng/mL[@bib42]*E. coli*Au electrodepolyclonal anti-*E. coli*EIS; Fe(CN)~6~^3-^2 CFU/mL[@bib19]*E. coli*AuNPs on reduced graphene oxide microelectrodeanti-*E. coli*EIS; Fe(CN)~6~^3-/4-^150 CFU/mL[@bib297]*E. coli*Ag/AgCl wire electrodeanti-*E. coli*EIS10 CFU/mL[@bib132]murine norovirus (MNV)AuNPs on carbon electrodeanti-norovirus (MNV) aptamerSWV, fluorescence; Fe(CN)~6~^3-^/Ru(NH~3~)~6~^3+^180 viruses[@bib90]rotavirusreduced graphene oxide microelectrodeanti-rotavirusamperometry100 PFU[@bib170]*S. typhimurium*AuNP-functionalized poly(amidoamine)-CNT-chitosan composite on carbon electrodeanti- *S. typhimurium*CV, EIS; Fe(CN)~6~^3-/4-^500 CFU/mL[@bib69]*E. coli*Au-tungsten microwire electrodemonoclonal anti-*E. coli*EIS; Fe(CN)~6~^3-/4-^5 CFU/mL[@bib172]*E. coli*Pt wire electrodeanti-*E. coli*EIS10 CFU/mL[@bib40]*S. aureus*reduced graphene oxide on carbon rod electrodeanti-*S. aureus* aptamerpotentiometry1 CFU/mL[@bib107]*E. coli*PAA/PD/CNT composite on carbon electrodeanti-*E. coli*ASV13 CFU/mL[@bib43]*S. typhimurium*AuNPs on graphene oxide on carbon electrodeanti-*S. typhimurium* aptamerEIS; Fe(CN)~6~^3-/4-^3 CFU/mL[@bib179]*S. aureus*AuNPs on reduced graphene oxide on carbon electrodeanti-*S. aureus* synthetic aptamerEIS; Fe(CN)~6~^3-/4-^10 CFU/mL[@bib126]*E. coli*Au electrodemannose carbohydrate ligandCV, mass change1 CFU/mL[@bib319]*L. monocytogenes*Au interdigitated microelectrode arrayleucocin A antimicrobial peptideEIS10^3^ CFU/mL[@bib80]*S. typhimurium*Au interdigitated microelectrode arraymonoclonal anti*-S. typhimurium*EIS3 × 10^3^ CFU/mL[@bib61]*S. aureus*Au electrodepolyclonal anti-*S. typhimurium*EIS; Fe(CN)~6~^3-/4-^10 CFU/mL[@bib24]*E. coli*CNTs on Au electrodeclavanin A peptideEIS; Fe(CN)~6~^3-/4-^100 CFU/mL[@bib10]*Klebsiella pneumoniae*CNTs on Au electrodeclavanin A peptideEIS; Fe(CN)~6~^3-/4-^10^3^ CFU/mL[@bib10]*Enterococcus faecalis*CNTs on Au electrodeclavanin A peptideEIS; Fe(CN)~6~^3-/4-^10^3^ CFU/mL[@bib10]*B. subtilis*CNTs on Au electrodeclavanin A peptideEIS; Fe(CN)~6~^3-/4-^100 CFU/mL[@bib10]*E. coli*PEI/CNT composite on carbon electrode*E. coli-*specific bacteriophagesEIS; Fe(CN)~6~^3-/4-^50 CFU/mL[@bib336]dengue virus 1--4AuNPs on Au electrodeanti-DENV-1, anti-DENV-2, anti-DENV-3, anti-DENV-4CV, EIS; Fe(CN)~6~^3-/4-^--[@bib176]*E. coli*ITO microelectrodemonoclonal anti-*E. coli*EIS; Fe(CN)~6~^3-/4-^1 CFU/mL[@bib20]avian influenza virus (AIV) H5N1Au interdigitated microelectrode arraymonoclonal anti-AIV-H5N1EIS; Fe(CN)~6~^3-/4-^4 HAU/mL[@bib166]*C. parvum*AuNPs on carbon electrodeanti-*C. parvum* aptamerSWV; Fe(CN)~6~^3-/4-^100 oocysts[@bib120]*E. coli*CNT-coated Au-tungsten microwire electrodespolyclonal anti-*E. coli*amperometry100 CFU/mL[@bib313]*S. aureus*CNT-coated Au-tungsten microwire electrodespolyclonal anti-*S. aureus*amperometry100 CFU/mL[@bib313]*S. aureus*Au interdigitated microelectrode arrayanti-*S. aureus*EIS; Fe(CN)~6~^3-/4-^1.3 CFU/mL[@bib221]*L. monocytogenes*Au interdigitated microelectrode arrayanti-*L. monocytogenes*EIS; Fe(CN)~6~^3-/4-^5 CFU/mL[@bib221]norovirusAu microelectrodeanti-norovirus aptamerSWV; Fe(CN)~6~^3-^/Ru(NH~3~)~6~^3+^10 PFU/mL[@bib138]avian influenza virus (AIV) H5N1Au interdigitated microelectrode arrayanti-AIV-H5N1 aptamerEIS; Fe(CN)~6~^3-/4-^4.2 HAU/mL[@bib35]*S. typhimurium*poly\[pyrrole-co-3-carboxyl-pyrrole\] copolymer electrodeanti-*S. typhimurium* aptamerEIS3 CFU/mL[@bib253]*E. coli*polysilicon interdigitated microelectrodespolyclonal anti*-E. coli*EIS--[@bib183]human influenza A virus H3N2Au electrodephenotype-specific oligoethylene glycol moietiesEIS1.3 × 10^4^ viruses/mL[@bib117]*E. coli*PEI/CNT composite on Au microwire electrodepolyclonal anti-*E. coli*amperometry100 CFU/mL[@bib158]*V. cholerae*CeO~2~ nanowires on Pt microelectrodeanti-*V. cholerae*EIS; Fe(CN)~6~^3-/4-^100 CFU/mL[@bib270]*S. aureus*PEI/CNT composite on Au microwire electrodepolyclonal anti-*S. aureus*amperometry100 CFU/mL[@bib158]*E. coli*graphene microelectrodepolyclonal anti-*E. coli*amperometry5 × 10^3^ CFU/mL[@bib306]*E. coli*Au electrodeconcanavalin A lectinEIS; Fe(CN)~6~^3-/4-^75 cells/mL[@bib316]*E. coli*Pt wire electrodesanti-*E. coli*EIS100 CFU/mL[@bib273]*S. aureus*Pt wire electrodesanti-*S. aureus*EIS100 CFU/mL[@bib273]*B. subtilis*CNTs on Au interdigitated microelectrode arraypolyclonal anti-*B. subtilis*conductometry100 CFU/mL[@bib323]*S. epidermidis*Au microelectrode*S. epidermidis*-imprinted poly(3-aminophenylboronic acid) polymer filmEIS; Fe(CN)~6~^3-/4-^10^3^ CFU/mL[@bib91]norovirusgraphene/AuNP composite on carbon electrodeanti-norovirus aptamerDPV; Ferrocene100 pM[@bib41]norovirusAu electrodesynthetic norovirus-specific peptideCV, EIS; Fe(CN)~6~^3-/4-^7.8 copies/mL[@bib118]*E. coli*CuO/cysteine/reduced graphene/Au oxide electrodemonoclonal anti-*E. coli*EIS; Fe(CN)~6~^3-/4-^3.8 CFU/mL[@bib210]Japanese encephalitis virus (JEV)carbon NPs on carbon electrodemonoclonal anti-JEVCV, EIS; Fe(CN)~6~^3-/4-^2 ng/mL[@bib50]*S. aureus*CNTs on carbon electrodepolyclonal anti-*S. aureus*DPV; Fe(CN)~6~^3-/4-^13 CFU/mL[@bib27]human influenza A virus H1N1PEDOT film electrodehemagglutinin-specific trisaccharide ligandEIS, potentiometry, mass change; Fe(CN)~6~^3-/4-^0.013 HAU[@bib101]human influenza A virus H1N1reduced graphene oxide on Au microelectrodemonoclonal anti-H1N1chrono-amperometry; Fe(CN)~6~^3-/4-^0.5 PFU/mL[@bib262]*E. coli*Au microelectrode*E. coli-*imprinted MAH/HEMA polymer filmcapacitive70 CFU/mL[@bib119]*E. coli*chitosan/polypyrrole/CNT/AuNP composite on graphite electrodemonoclonal *coli*CV; Fe(CN)~6~^3-/4-^30 CFU/mL[@bib97]*S. dysenteriae*AuNPs on carbon electrodeanti-*S*. *dysenteriae* aptamerEIS; Fe(CN)~6~^3-/4-^1 CFU/mL[@bib325]human influenza A virus H1N1PEDOT:PSS film electrodehemagglutinin-specific trisaccharide ligandamperometry0.015 HAU[@bib102]*S. aureus*fluoride-doped tin oxide electrode*S. aureus-*imprinted Ag--MnO~2~ filmDPV; Fe(CN)~6~^3-/4-^10^3^ CFU/mL[@bib68]*E. coli*Au microelectrode*E. coli*-imprinted TEOS/MTMS sol-gel filmEIS; Fe(CN)~6~^3-/4-^1 CFU/mL[@bib121]norovirusAu electrodenorovirus-specific peptideEIS; Fe(CN)~6~^3-/4-^1.7 copies/mL[@bib14]*C. parvum*Au interdigitated microelectrode arraymonoclonal anti-*C. parvum*Capacitive; Fe(CN)~6~^3-/4-^40 cells/mm^2^[@bib174]*E. coli*4-(3-pyrrol) butryic acid electrodeconcanavalin A lectin, *Arachis hypogaea* lectinEIS6 × 10^3^ CFU/mL[@bib240]*B. subtilis*4-(3-pyrrol) butryic acid electrodeconcanavalin A lectin, *Arachis hypogaea* lectinEIS6 × 10^3^ CFU/mL[@bib240]*E. coli*silica NPs on polyelectrolyte multilayer on Au electrodepolyclonal anti-*E. coli*CV; Fe(CN)~6~^3-/4-^2 × 10^3^ CFU/mL[@bib190]*E. coli*silica NPs on polyelectrolyte multilayer on Au electrodepolyclonal anti-*E. coli*CV; Fe(CN)~6~^3-/4-^2 × 10^3^ CFU/mL[@bib190]

### 2.1.2. Ceramic electrodes {#sec2.1.2}

Conducting and semiconducting ceramics, including indium tin oxide (ITO), polysilicon, and titanium dioxide (TiO~2~) have also been examined for pathogen detection. For example, Das et al. used a silicon electrode for *Salmonella typhimurium* (*S. typhimurium*) detection ([@bib60]). Barreiros dos Santos et al. developed an antibody-functionalized ITO electrode for the detection of *E. coli*with a dynamic range of 10--10^6^ CFU/mL ([@bib20]). In addition to high conductivity, ITO is transparent, which presents various measurement advantages, including the ability to accurately correlate biosensor response with pathogen surface coverage ([@bib13]; [@bib317]). Transparent electrodes also enable *in situ* verification of target binding via microscopic techniques and offer compatibility with optical approaches, such as those based on optical stimulation ([@bib300]). Carbon electrodes based on various allotropes of carbon, such as graphite and glass-like carbon, can also be classified as ceramic materials due to their mechanical properties (*e.g.,* brittleness).

### 2.1.3. Polymer electrodes {#sec2.1.3}

Polymers have also been investigated as electrodes for pathogen detection. Polymers have various advantages, including tunable electrical conductivity, biocompatiblity, and environmentally stability. Polymer electrodes are also compatible with a range of biorecognition element immobilization techniques ([@bib11]; [@bib96]). Polymers also exhibit mechanical properties that enable electrode-tissue mechanical matching, an important consideration in the design of implantable and wearable biosensors. Polymer electrodes can be broadly classified as (1) conjugated polymer or (2) polymer composite.

Polyaniline and polypyrrole have been the most commonly used conjugated polymers for pathogen detection due to their high conductivity in the doped state ([@bib135]). Moreover, polypyrrole has been shown to be biocompatible and exhibit affinity for methylated nucleic acids ([@bib11]). However, polyaniline films lose electrochemical activity in solutions of pH greater than 4, which presents a measurement challenge when considering samples of varying pH ([@bib288]). Conjugated polymer electrodes commonly exhibit thin-film form factors and are deposited onto insulating substrates via layer-by-layer approaches, spin coating, or electrochemical polymerization ([@bib308]). For example, Chowdhury et al. used a polyaniline electrode for detection of *E. coli* over a dynamic range of 10^2^ to 10^7^ CFU/mL ([@bib52]). Hai et al. and He et al. used organic transistors based on spin-coated poly(3,4-ethylenedioxythiophene):polystyrene sulfonate (PEDOT:PSS) films for detection of human influenza A virus (H1N1) and *E. coli*, respectively ([@bib102]; [@bib106]).

Polymer composite electrodes are often composed of a non-conducting polymer mixed with a conducting or semiconducting dispersed phase. Micro-particles and nanomaterials, such as graphite, Au nanoparticles (AuNPs), graphene, and carbon nanotubes (CNTs), have been commonly used as the dispersed phase ([@bib69]; [@bib157]; [@bib158]; [@bib161]; [@bib284]) in combination with various polymers, including chitosan ([@bib97]), polyethylenimine (PEI) ([@bib158]), and polyallyamine ([@bib284]). For example, Viswanathan et al. developed a polyallylamine/CNT polymer composite electrode for the detection of *E. coli, S. typhimurium,* and *Campylobacter* via anodic stripping voltammetry over the dynamic range of 10^3^ to 10^5^ cells/mL ([@bib284]). A multicomponent polymer composite electrode of poly(amidoamine), CNTs, and chitosan layered with AuNPs enabled the detection of *S. typhimurium* ([@bib69]). The detection limits associated with polymer composite electrodes are comparable to metallic and polymer electrodes and range from 1 to 10^3^ CFU/mL (see [Table 1](#tbl1){ref-type="table"}). While polymer composite electrodes often contain nanomaterials, they are dispersed throughout the bulk of polymer, which is in contrast to the electrode nanostructuring techniques that occur at the electrode surface and are discussed in the following sections.

Polymer electrode development has been, in part, driven by the need for flexible biosensors. For example, free-standing film electrodes and polymer electrodes on flexible substrates, such as paper, are now being examined for biosensing applications ([@bib309]). Given conjugated polymers and polymer composites are compatible with 3D printing processes ([@bib142]), polymer electrodes are also emerging as attractive candidates for wearable conformal (*i.e.,* form-fitting) biosensors. While polymer electrodes typically exhibit planar form factors, such as thin films, they can also be constructed as nanowires and nanofibers, as discussed in the following section. A comprehensive discussion of biosensor LOD and dynamic range for all electrode materials is provided in [Table 1](#tbl1){ref-type="table"}, [Table 2](#tbl2){ref-type="table"} .Table 2Classification of electrochemical biosensors employing labels for pathogen detection in terms of: target, working electrode, biorecognition element, electrochemical method, limit of detection, electrochemical probe, and label or secondary processing step. *Abbreviations*: quartz crystal microbalance (QCM), electrochemical impedance spectroscopy (EIS), cyclic voltommetry (CV), plaque-forming unit (PFU), colony-forming unit (CFU), indium tin oxide (ITO), carbon nanotube (CNT), magnetic bead (MB), nanoparticle (NP), differential pulse voltammetry (DPV), square wave voltammetry (SWV), anodic stripping voltammetry (ASV), hemagglutination units (HAU), and median tissue culture infectious dose (TCID~50~).Table 2Target PathogenWorking ElectrodeBiorecognition ElementElectrochemical Method & ProbeLimit of DetectionSecondary Binding StepReference*E. coli*ITO electrodeanti-*E. coli*EIS; Fe(CN)~6~^3-/4-^6 × 10^5^ cells/mLantibody/ALP conjugate label for amplification[@bib317]*V. cholerae*carbon/polystyrene electrodepolyclonal anti-*V.cholerae*chrono-amperometry10^5^ cells/mLantibody-ALP conjugate label for amplification[@bib226]*E. coli*Au interdigitated microelectrode arraypolyclonal anti-*E. coli*EIS2.67 × 10^6^ cells/mLantibody-coated MBs for separation[@bib279]*V. parahaemolytic*carbon electrodeanti-*V. parahaemolytic*CV; thionine/hydrogen peroxide7.37 × 10^4^ CFU/mLantibody/HRP conjugate label for transduction[@bib333]*E. coli*Au interdigitated microelectrode arraypolyclonal anti-*E. coli*EIS7.4 × 10^4^ CFU/mLantibody-coated MBs for separation and amplification[@bib277]*E. coli*AuNPs on carbon electrodemonoclonal and polyclonal anti-*E. coli*CV; ferrocenedicarboxylic acid/hydrogen peroxide6 CFU/mLpolyclonal antibody/HRP conjugate label for amplification[@bib167]*S. aureus*Au electrodeanti-*S. aureus*amperometry; tetrathiafulvalene/hydrogen peroxide370 cells/mLantibody/HRP conjugate label for amplification[@bib76]*S. typhimurium*Au electrodemonoclonal anti-*S. typhimurium*chrono-amperometry; tetramethylbenzidine dihydrochloride/hydrogen peroxide21 CFU/mLanti-*S. typhimurium* polyclonal antibody/HRP conjugate label for amplification[@bib238]*S. typhimurium*graphite-epoxy composite electrodepolyclonal anti-*S. typhimurium*amperometry0.1 CFU/mLprimary antibody-coated MBs for separation, secondary antibody/HRP conjugate label for amplification[@bib165]avian influenza virus (AIV) H5N1Au interdigitated microelectrode arraymonoclonal anti-AIV-H5EIS0.26 HAU/mLantibody-coated MBs for separation[@bib295]*Streptococcus pneumoniae*Au electrodepolyclonal anti-*S. pneumonia*eamperometry; tetrathiafulvalene/hydrogen peroxide1.5 × 10^4^ CFU/mLantibody-coated MBs for separation and bacteria immobilization, antibody/HRP conjugate label for amplification[@bib36]*E. coli*carbon-graphite electrodemonoclonal anti-*E. coli*CV7 CFU/mLantibody-coated MBs for separation, antibody/polyaniline label for amplification[@bib248]*S. aureus*MBs on Au electrodepolyclonal anti-Protein A (*S. aureus*)amperometry; tetrathiafulvalene/hydrogen peroxide1 CFU/mLantibody/Protein A/HRP conjugate for amplification[@bib78]avian influenza virus (AIV) H5N1Au interdigitated microelectrode arraymonoclonal anti-AIV-H5, polyclonal anti-AIV-N1EIS10^3^ EDI~50~/mLanti-AIV-H5 monoclonal antibody- coated MBs for separation, red blood cell label for amplification[@bib175]*E. coli*AuNPs/SiO~2~ nanocomposite on sulfhydryl chitosan/Fe(C~2~H~5~)~2~/C~60~ composite on carbon electrodemonoclonal anti-*E. coli*CV; ferrocene15 CFU/mLantibody/glucose oxidase/Pt nanochain conjugate label for amplification[@bib162]*C. parvum*polypyrrole-coated carbon electrodepolyclonal anti-*C. parvum*chrono-potentiometry; *o*-phenylenediamine/hydrogen peroxide500 oocysts/mLantibody/HRP conjugate label for amplification[@bib148]*L. monocytogenes*polymeric ion-selective membrane electrodeanti-*L. monocytogenes* InlA aptamerpotentiometry10 CFU/mLaptamer/protamine label for transduction[@bib67]avian influenza virus (AIV) H5N1Au interdigitated electrode arrayanti-AIVH5N1 aptamerEIS0.04 HAU/mLaptamer-coated MBs for separation, Concanavalin A/glucose oxide-coated AuNP labels for amplification[@bib85].*L. monocytogenes*interdigitated microelectrode arraymonoclonal and polyclonal anti-*L. monocytogenes*EIS300 CFU/mLmonoclonal antibody-coated MBs for separation, polyclonal antibody-coated AuNP label for secondary binding amplification[@bib45]*E. coli*carbon electrodepolyclonal anti-*E.coli*chrono-amperometry148 CFU/mLprimary antibody-coated MBs for separation, secondary antibody-coated AuNPs for amplification[@bib104]avian influenza virus (AIV) H5N1AuNPs on ITO microelectrodepolyclonal anti-AIVH5N1ASV10 pg/mLantibody-coated MBs for separation and anodic stripping[@bib334]*E. coli*Au interdigitated microelectrode arrayanti-*E.coli*EIS; Fe(CN)~6~^3-/4-^100 CFU/mLwheat germ agglutinin for amplification[@bib164]*E. coli*carbon electrodemonoclonal and polyclonal anti-*E. coli*DPV10 CFU/mLmonoclonal antibody-coated MBs for separation, polyclonal antibody-coated AuNP label for amplification[@bib296]norovirusnanostructured Au microelectrodeconcanavalin A lectin, polyclonal anti-norovirusCV, EIS; Fe(CN)~6~^3-/4-^35 copies/mLantibody-ALP conjugate label for amplification[@bib110]*Legionella pneumophila*carbon electrodepolyclonal anti-*L. pneumophila*amperometry; hydroquinone/hydrogen peroxide10 CFU/mLprimary antibody- coated MBs for separation, secondary antibody/HRP conjugate label for amplification[@bib188]*S. aureus*carbon electrodeanti-*S.aureus* aptamerASV1 CFU/mLprimary aptamer-coated MBs for separation, secondary aptamer-coated AgNP label for anodic stripping[@bib1]*L. monocytogenes*Au interdigitated microelectrode arraymonoclonal and polyclonal anti-*L. monocytogenes*EIS160 CFU/mLmonoclonal antibody-coated MBs for separation, polyclonal antibody-coated AuNP label for amplification[@bib46]*E. coli*Au interdigitated microelectrode arraypolyclonal anti-*E. coli*CV, amperometry52 CFU/mLantibody-coated, AuNP/glucose oxidase-modified MBs for separation and amplification[@bib310]*E. coli*Au interdigitated microelectrode arrayanti- *E. coli*EIS100 CFU/mLantibody-coated MBs for separation, antibody/glucose oxidase conjugate for amplification[@bib311]*S. typhimurium*Au interdigitated microelectrode arraymonoclonal anti-*S. typhimurium*EIS100 CFU/mLantibody-coated MBs for separation, antibody/glucose oxidase conjugate label for amplification[@bib311]*E. coli*chitosan/CNT composite on carbon electrodepolyclonal anti*-E. coli*CV; thionine/hydrogen peroxide50 CFU/mLsecondary antibody/HRP conjugate label enzyme-assisted reduction reaction[@bib87]*S. typhimurium*carbon electrodepolyclonal and monoclonal anti-*S. typhimurium*DPV100 cells/mLpolyclonal antibody- coated MBs for separation, monoclonal antibody- coated AuNP label for amplification[@bib3]*E. coli*Au electrodeanti-*E. coli*EIS; Fe(CN)~6~^3-/4-^100 CFU/mLAuNP label for amplification[@bib287]*L. monocytogenes*Au interdigitated electrode arraypolyclonal anti-*L. monocytogenes*EIS1.6 × 10^3^ CFU/mLantibody-coated MBs for separation, antibody-coated AuNP label for amplification[@bib293]*E. coli*Au microelectrodemonoclonal anti-*E. coli*LSV39 CFU/mLantibody-coated MBs for separation, antibody/AuNP/nucleotide/CdSNP conjugate label for amplification[@bib163]*V. cholerae*Au microelectrodepolyclonal anti-*V. cholerae*LSV32 CFU/mLantibody-coated MBs for separation, antibody/AuNP/nucleotide/PbSNP conjugate label for amplification[@bib163]avian influenza virus (AIV) H5N1Au electrodeanti-AIVH5N1, concanavalin A lectinCV0.367 HAU/mLConcanavalin A- coated MB labels for amplification[@bib331]human influenza A virus H9N2carbon electrodepolyclonal anti-influenza A virus M2 protein, fetuin Achrono-amperometry16 HAUantibody-coated MBs for separation, fetuin A-coated AuNP label for amplification[@bib242]human enterovirus 71 (EV71)AuNPs on ITO electrodemonoclonal anti-EV71CV, EIS, colorimetry; Fe(CN)~6~^3-/4-^10 pg/mLantibody/HRP-coated MB labels for amplification[@bib112]*E. coli*Ag interdigitated microelectrode arraymelittin peptideEIS1 CFU/mLMLT-coated MBs used for separation and bacteria immobilization[@bib305]*S. typhimurium*Ag interdigitated electrode arraymelittin peptideEIS10 CFU/mLMLT-coated MBs used for separation and bacteria immobilization[@bib305]*S. aureus*Ag interdigitated electrode arraymelittin peptideEIS110 CFU/mLMLT-coated MBs used for separation and bacteria immobilization[@bib305]Middle East respiratory syndrome corona virus (MERS-CoV)AuNPs on carbon electrodeMERS-CoV antigen-antibody complexSWV; Fe(CN)~6~^3-/4-^400 fg/mLMERS CoV-antibody complex[@bib153]

### 2.1.4. Electrode form factor and patterning {#sec2.1.4}

As shown in [Table 1](#tbl1){ref-type="table"}, Au electrodes of various size and form factor have been used for pathogen detection. The use of complex masks and programmable tool paths with lithographic and 3D printing processes, respectively, also enable the fabrication of complex electrode geometries ([@bib39]; [@bib312]). In addition to complex form factor, lithographic processes, 3D printing processes, and assembly operations also enable the fabrication of electrode arrays through electrode patterning ([@bib109]). Electrode arrays, including interdigitated microelectrodes and other patterned electrodes, have been developed in an attempt to enhance the sensitivity and multiplexing capability of biosensors. Interdigitated array microelectrodes (IDAMs) consist of alternating, parallel-electrode fingers organized in an interdigitated pattern. IDAMs have been shown to exhibit rapid response and high signal-to-noise ratio ([@bib278]). As shown in [Table 1](#tbl1){ref-type="table"}, Au interdigitated microelectrode arrays are one of the most common electrode configurations for pathogen detection. For example, Dastider et al. usedinterdigitated Au microelectrode arrays for detection of *S. typhimurium* via EIS (see [Fig. 4](#fig4){ref-type="fig"}a) ([@bib61]). Ceramic electrodes, such as ITO, with interdigitated array designs have also been examined for the detection of *S. typhimurium* ([@bib318]). Mannoor et al. also examined interdigitated carbon-based electrodes for pathogen detection ([@bib185]). The aforementioned emerging manufacturing processes are also used to construct electrode arrays that exhibit geometries other than interdigitated designs for electrochemical sensing applications. For example, Yang et al. used aerosol jet additive manufacturing to fabricate silver (Ag) microelectrode arrays ([@bib315]).

### 2.1.5. Electrode nanostructuring {#sec2.1.5}

Transducers with physical dimensions comparable to the target species have been widely investigated as a means of creating sensitive biosensors ([@bib99]; [@bib222]; [@bib259]; [@bib299]). Thus, electrodes ranging from micrometers to nanometers have been investigated for pathogen detection. While nanoscale planar electrodes are among the most commonly examined for pathogen detection ([@bib110]; [@bib216]), the fabrication of nanoscale structures of conducting and semiconducting materials using a wide range of bottom-up and top-down nanomanufacturing processes, such as nanowires, has led to the investigation of nanostructured electrodes for pathogen detection ([@bib212]). Nanostructuring can be performed simultaneously with bottom-up electrode fabrication processes or as a post-processing step with top-down electrode fabrication processes.

Nanowire-based electrodes have been fabricated using a variety of engineering materials using both bottom-up and top-down nanomanufacturing processes ([@bib113]; [@bib322]). A detailed review of nanomanufacturing processes for nanowire fabrication can be found elsewhere ([@bib113]). Nanowires can exhibit circular, hexagonal, and even triangular cross-sections. The nanowire aspect ratio, defined as the ratio of the length to width, often ranges from 1 to greater than 10 ([@bib113]; [@bib280]; [@bib292]).

As shown in [Table 1](#tbl1){ref-type="table"}, metallic and ceramic microwire- and nanowire-based electrodes have been examined for pathogen detection. For example, Wang et al. used nanowire-bundled TiO~2~ electrodes synthesized using a bottom-up wet chemistry process for the detection of *Listeria monocytogenes* (*L. monocytogenes*) ([@bib294]). Shen et al. fabricated silicon nanowire-based electrodes using a chemical vapor deposition process for the rapid detection of human influenza A virus in an array-based format ([@bib254]).

Although polymer nanowires have been relatively more applied to the detection of non-pathogenic species ([@bib276]), there appears to be potential for their application to pathogen detection. Polymer nanowires are also synthesized via bottom-up and top-down nanomanufacturing processes, including hard template methods, soft template methods, or physical approaches, but efficient, large-scale synthesis remains a challenge ([@bib308]). A comprehensive summary of studies using micro- and nano-wire electrodes for pathogen detection is shown in [Table 1](#tbl1){ref-type="table"}. For example, Chartuprayoon et al. used Au microelectrode arrays modified with polypyrrole nanoribbons to detect cucumber mosaic virus ([@bib42]).

The topographical modification of electrode surfaces with micro- and nano-structured features beyond wire-like structures has also been investigated for pathogen detection. Electrode nanostructuring increases the electrode surface area without significantly increasing the electrode volume, thereby increasing the ratio of electrode surface area to fluid volume analyzed ([@bib263]). Topographical modification of electrodes can also affect their mechanical and electrical properties. For example, electrochemical deposition of PEDOT on silicon electrodes reduces the electrode electrical impedance across a wide frequency range, which offers measurement advantages for neural monitoring and recording applications ([@bib173]).

Electrode nanostructuring for pathogen detection beyond the fabrication of nanowire-based electrodes has been accomplished primarily using bottom-up wet chemistry approaches and electrochemical methods. Among the wet chemistry approaches for electrode nanostructuring ([@bib74]), nanostructured electrodes are often fabricated by the deposition or coupling of nanoparticles to planar electrodes. For example, AuNPs are commonly deposited on planar electrodes to provide a nanostructured surface for biorecognition element immobilization. In such studies, the particles are bound to the planar electrode via physical adsorption processes ([@bib12]) or chemical methods ([@bib297]). In addition to AuNPs, CNTs have also been extensively investigated as potentially useful nanomaterials for electrode nanostructuring (see [Table 1](#tbl1){ref-type="table"}).

De Luna et al. found that high-curvature nanostructured Au microelectrodes exhibited a reduced extent of biorecognition element aggregation relative to that found on planar electrodes in DNA sensing studies using a combination of experimental studies and molecular dynamics simulations (see [Fig. 3](#fig3){ref-type="fig"} a) ([@bib65]; [@bib181]). A study by Chin et al. found that nanostructuring of carbon electrodes with carbon nanoparticles enhanced the electron transfer kinetics and current intensity of the electrode by 63% for the detection of Japanese encephalitis virus ([@bib50]).Fig. 3Emerging transduction approaches associated with electrochemical biosensors for pathogen detection. **a**) A nanostructured Au microelectrode array with high curvature ([@bib65]). **b**) Cell-imprinted polymer (CIP) with 'artificial' biorecognition elements for detection of *E. coli* using electrochemical impedance spectroscopy (EIS) and the Fe(CN)~6~^3-/4-^ redox probe ([@bib121]).Fig. 3Fig. 4Measurement settings associated with electrochemical biosensor-based multiplexed pathogen detection. **a**) Microfluidic device with an interdigitated Au microelectrode array for continuous measurement of *S. typhimurium* ([@bib61]). **b**) Conjugated nanoparticles with two different biorecognition elements for *E. coli* and *V. cholerae* detection via voltammetry using Fe(CN)~6~^3-/4-^ ([@bib163]). **c**) Schematic of a microfluidic device with two separate spatial regions of biorecognition elements for *E. coli* and *S. aureus* ([@bib273]).Fig. 4

In addition to fabricating nanostructured electrodes by coupling already processed nanomaterials to planar electrodes, electrochemical methods are also commonly used for bottom-up electrode nanostructuring processes and have been leveraged to fabricate nanostructured electrodes for pathogen detection. For example, Hong et al. fabricated a nanostructured Au electrode via electrochemical deposition of gold (III) chloride hydrates for the detection of norovirus in lettuce extracts ([@bib110]). While the physical or chemical deposition of materials on planar electrodes provides a useful nanostructuring approach, introducing porosity to the electrode, such as nanoporosity, also enables electrode nanostructuring. For example, Nguyen et al. utilized nanoporous alumina-coated Pt microwires for the detection of West Nile virus ([@bib203]).

While studies have reported improved biosensor performance using electrode nanostructuring, such as improved sensitivity and LOD, it is prudent to consider the effect of nanostructuring on biorecognition element immobilization and target binding. For example, nanostructured electrodes that exhibit high-aspect-ratio structures and other three-dimensional structures have also been shown to enhance biomolecular steric hindrance effects, which may have implications for pathogen detection applications ([@bib110]; [@bib151]; [@bib182]). There also remains a need to understand device-to-device and batch-to-batch variation in electrode nanostructuring quality. For example, it is presently unclear how the structure (*e.g.,* topography, crystal structure) and material properties (*e.g.,* electrical properties) of nanostructured surfaces vary among mass-produced electrodes. It is also unclear how such variance in nanostructuring quality affects the repeatability of biosensor performance.

### 2.1.6. Integration of complementary transduction elements {#sec2.1.6}

Given the need for rapid and reliable measurements, biosensors that contain integrated electrodes and complementary transducers have also been examined for pathogen detection applications. For example, electrodes have been integrated with transducers that enable simultaneous fluid mixing and monitoring of molecular binding events ([@bib51]). Biosensors composed of multiple transducers, referred to as hybrid biosensors, also offer unique opportunities for *in situ* verification of target binding as well as complementary analytical measurements (*i.e.,* dual detection).

Hybrid electrochemical biosensors for pathogen detection have been developed by integrating electrodes with optical and mechanical transducers. Electrochemical-optical waveguide light mode spectroscopy (EC-OWLS) combines evanescent-field optical sensing with electrochemical sensing ([@bib22]). EC-OWLS optically monitors changes and growth at the electrode surface to provide complementary information on surface reactions. EC-OWLS has been used to monitor the growth of bacteria ([@bib202]) and could potentially be applied to selective detection of pathogens. Electrochemical-surface plasmon resonance (EC-SPR) combines SPR sensing capability based on binding-induced refractive index changes at the electrode-electrolyte interface with electrochemical sensing capability on the same electrode ([@bib114]). This approach has been used for monitoring molecular binding events ([@bib133]) and could potentially be applied to selective detection of pathogens.

In addition to their combination with optical transducers, hybrid electrochemical biosensors have also been combined with mechanical transducers. Mechanical transducers have included shear-mode resonators, such as the quartz crystal microbalance (QCM) and cantilever biosensors. Electrochemical-QCMs (E-QCMs) integrate mass-change and electrochemical sensing capabilities into a single platform. For example, Li et al. used an antibody-functionalized E-QCM for the detection of *E. coli*, which provided complementary cyclic voltammetry, EIS, and capacitive sensing measurements associated with the detection response ([@bib160]). Serra et al. used a lectin-modified E-QCM to detect *E. coli* using the biosensor\'s mass-change response ([@bib247]).

Besides providing complementary responses for verification of binding events ([@bib128], [@bib129]), hybrid biosensors for pathogen detection can also generate fluid and particle mixing at the electrode-electrolyte interface and in the bulk solution via acoustic streaming or primary radiation effects of mechanical transducers ([@bib39]). Thus, secondary transducers can apply force to bound species, such as nonspecifically adsorbed background species or captured target species. For example, various studies have reported the removal of surface-bound biomolecules using mechanical transducers, such as shear-mode resonators or cantilever biosensors ([@bib131]; [@bib321]). While the impediment or removal of nonspecifically adsorbed background species is a vital biosensor characteristic in pathogen detection applications that involve complex matrices, the regeneration of biosensor surfaces that contain specifically bound target species is essential for applications involving high-throughput characterization or process monitoring (*e.g.,* bioprocesses or biomanufacturing processes) ([@bib92]). Hybrid designs may also be useful for electrodes that exhibit a high extent of biofouling.

In addition to hybrid biosensor designs composed of combinations of electrodes with other transducers, hybrid biosensor-based assays for pathogen detection based on the combination of an electrochemical biosensor with a traditional bioanalytical technique have also been utilized. For example, electrochemical-colorimetric (EC-C) biosensing combines an electrochemical method and a colorimetric, fluorescent, or luminescent detection method. The electrode detects the presence of a target species, while the colorimetric transduction pathway enables quantification of the products associated with the reaction between the target and an active species ([@bib112]). For example, Hou et al. used an EC-C approach based on a monoclonal antibody-functionalized AuNP-modified ITO electrode and dual-labeled magnetic beads for the detection of human enterovirus 71 ([@bib112]). In that study, antibody- and horseradish peroxidase (HRP)-labeled magnetic nanobeads were introduced as a secondary binding step following exposure of the electrode to enterovirus-containing samples. Following the secondary binding step, the HRP-nanobead conjugates enabled colorimetric detection via monitoring of oxidative products produced by HRP-catalyzed redox reactions, while the functionalized electrode enabled electrochemical detection via chronoamperometry. Various techniques often rely on the use of optically-active labels for colorimetric, fluorescent, or luminescent sensing. The optical labels used in pathogen detection applications commonly include biological fluorophores, such as green fluorescent protein, non-protein organic fluorophores, such as fluorescein and rhodamine, and nanoparticles, such as quantum dots, including CdS, CdSe, and GaAs, among others ([@bib199]; [@bib218]). The use of such additional reagents to detect the target species is discussed further in the following sections.

2.2. Biorecognition elements {#sec2.2}
----------------------------

The previous section discussed the transduction elements associated with pathogen detection using electrochemical biosensors. Given a biosensor is a device composed of integrated transducer and biorecognition elements, we next discuss the biorecognition elements used for selective detection of pathogens and corresponding immobilization techniques for their coupling to electrodes.

Biorecognition elements for electrochemical biosensors can be defined as (1) biocatalytic or (2) biocomplexing. In the case of biocatalytic biorecognition elements, the biosensor response is based on a reaction catalyzed by macromolecules. Enzymes, whole cells, and tissues are the most commonly used biocatalytic biorecognition element. While enzyzmes provide biorecognition elements in various chemical sensing applications, they are often used as labels for pathogen detection applications and most commonly introduced via secondary binding steps. In the case of biocomplexing biorecognition elements, the biosensor response is based on the interaction of analytes with macromolecules or organized molecular assemblies. As shown in [Table 1](#tbl1){ref-type="table"}, [Table 2](#tbl2){ref-type="table"}, antibodies, peptides, and phages are the most commonly used biocomplexing biorecognition elements for pathogen detection. In addition to biomacromolecules, imprinted polymers have also been examined as biocomplexing biorecognition elements for pathogen detection using electrochemical biosensors.

### 2.2.1. Antibodies and antibody fragments {#sec2.2.1}

Antibodies and antibody fragments are among the most commonly utilized biorecognition elements for pathogen detection using electrochemical biosensors. Biosensors employing antibody-based biorecognition elements are commonly referred to as immunosensors. Given antibodies exhibit high selectivity and binding affinity for target species and can be generated for a wide range of infectious agents, antibodies are the gold-standard biorecognition element for pathogen detection. Antibodies contain recognition sites that selectively bind to antigens through a specific region of the antigen, referred to as an epitope ([@bib213]). Antibodies can be labeled with fluorescent or enzymatic tags, which leads to the designation of the approach as label-based. While label-based approaches present measurement constraints associated with the use of additional reagents and processing steps ([@bib57]; [@bib239]), antibody labeling may also alter the binding affinity to the antigen, which could affect the biosensor\'s selectivity. A detailed discussion of label-based biosensing approaches for pathogen detection has been reported elsewhere ([@bib4]; [@bib6]; [@bib31]; [@bib159]). A list of recent label-based approaches for pathogen detection using electrochemical biosensors, however, is provided in [Table 2](#tbl2){ref-type="table"}.

While both monoclonal and polyclonal antibodies enable the selective detection of pathogens ([@bib213]), they vary in terms of production method, selectivity, and binding affinity. Monoclonal antibodies are produced by hybridoma technology ([@bib29]; [@bib123]). Thus, monoclonal antibodies are highly selective and bind to a single epitope, making them less vulnerable to cross-reactivity. While monoclonal antibodies tend to have a higher degree of selectivity, they are more expensive and take longer to develop than polyclonal antibodies. Polyclonal antibodies are produced by separation of immunoglobulin proteins from the blood of an infected host ([@bib29]). Polyclonal antibodies target different epitopes on a single antigen. While polyclonal antibodies exhibit increased variability between batches, they are relatively less expensive to produce than monoclonal antibodies and facilitate robust measurements in various settings ([@bib33]). Drawbacks to antibody use include high cost and stability challenges, such as the need for low-temperature storage. As shown in [Table 1](#tbl1){ref-type="table"}, [Table 2](#tbl2){ref-type="table"}, both monoclonal and polyclonal antibodies are used as biorecognition elements for pathogen detection. For assays involving secondary binding steps, monoclonal antibodies typically serve as the primary biorecognition element and are immobilized on the electrode, while polyclonal antibodies serve as the secondary biorecognition element and often facilitate target labeling. For assays that do not require secondary binding steps, polyclonal antibodies are also commonly used as immobilized biorecognition elements for pathogen detection. For example, Pandey et al. immobilized monoclonal anti-*E. coli* on a composite nanostructured electrode to detect *E. coli* across a wide dynamic range of 10 to 10^8^ CFU/mL with a LOD of 3.8 CFU/mL ([@bib210]). Wu et al. used polyclonal anti-*E. coli* for detection of *E. coli* via amperometry that exhibited a LOD of 5 × 10^3^ CFU/mL ([@bib306]). Lin et al. used monoclonal antibodies for detection of avian influenza virus H5N1 in chicken swabs across a dynamic range of 2^-^ ^1^ to 2^4^ hemagglutination units (HAU)/50 μL using EIS and the ferri/ferrocyanide (Fe(CN)~6~ ^3^ ^-^ ^/4-^) couple as a redox probe ([@bib166]). Luka et al. detected *Cryptosporidium parvum* (*C. parvum*) with a LOD of 40 cells/mm^2^ via capacitive sensing and Fe(CN)~6~ ^3^ ^-^ ^/4-^ ([@bib174]).

Antibody fragments, such as single-chain variable fragments (scFvs), offer selectivity similar to antibodies, but they have the advantage of achieving relatively higher packing densities on electrode surfaces due to their relatively smaller size. For example, half-antibody fragments have been shown to improve biosensor sensitivity without the loss of selectivity, which warrants further investigation of reduced antibodies as biorecognition elements for pathogen detection applications ([@bib251]). In addition to scFvs, Fabs, re-engineered IgGs, and dimers can also potentially be used as biorecognition elements for pathogen detection ([@bib33]).

### 2.2.2. Carbohydrate-binding proteins {#sec2.2.2}

Carbohydrate-binding proteins, such as lectins, also provide selective biorecognition elements for pathogen detection based on their ability to selectively bind ligands on target species. Peptide-based biorecognition elements are relatively low-cost, can be produced with high yield automated synthesis processes, and are modifiable ([@bib214]). For example, lectins have been investigated as biorecognition elements for pathogen detection through their ability to selectively bind glycosylated proteins on the surfaces of viruses and cells ([@bib231]). Concanavalin A (ConA) lectin has been extensively investigated for *E. coli* detection (see [Table 1](#tbl1){ref-type="table"}) ([@bib124]; [@bib240]; [@bib307]; [@bib316]). While not yet widely investigated for pathogen detection using electrochemical biosensors, Etayash et al. recently showed that oligopeptides also provide attractive biorecognition elements for real-time biosensor-based detection of breast cancer cells ([@bib79]).

### 2.2.3. Oligosaccharides {#sec2.2.3}

Trisaccharides are carbohydrates that can selectively bind carbohydrate-specific receptors on pathogens. Thus, trisaccharide ligands have been used as biorecognition elements for pathogen detection using electrochemical biosensors. For example, Hai et al. used a hybrid E-QCM biosensor coated with hemagglutinin-specific trisaccharide ligands for the detection of human influenza A virus (H1N1) ([@bib101]). The use of carbohydrates as biorecognition elements is limited in part due to the weak affinity of carbohydrate-protein interactions and low selectivity, which are currently mitigated through secondary interactions ([@bib329]).

### 2.2.4. Oligonucleotides {#sec2.2.4}

Single-stranded DNA (ssDNA) is a useful biorecognition element for the detection of pathogens. While ssDNA is commonly used as a biorecognition element for DNA-based assays, ssDNA aptamers are commonly used for pathogen detection using electrochemical biosensors. Aptamers are single-stranded oligonucleotides capable of binding various molecules with high affinity and selectivity ([@bib150]; [@bib233]). Aptamers are isolated from a large random sequence pool through a selection process that utilizes systematic evolution of ligands by exponential enrichment, also known as SELEX ([@bib266]). Suitable binding sequences can be isolated from a large random oligonucleotide sequence pool and subsequently amplified for use. Thus, aptamers can exhibit high selectivity to target species ([@bib266]). Aptamers can also be produced at a lower cost than alternative biorecognition elements, such as antibodies. Giamberardino et al. used SELEX to discover an aptamer for norovirus detection, which showed a million-fold higher binding affinity for the target than a random DNA strand that served as a negative control ([@bib90]). Iqbal et al. performed 10 rounds of SELEX to discover 14 aptamer clones with high affinities for *C. parvum* for detection in fruit samples ([@bib120]). However, the use of aptamers as biorecognition elements has not yet replaced traditional biorecognition elements, such as antibodies, because of several challenges, such as aptamer stability, degradation, cross-reactivity, and reproducibility using alternative processing approaches ([@bib150]).

### 2.2.5. Phages {#sec2.2.5}

Phages, also referred to as bacteriophages, are viruses that infect and replicate in bacteria through selective binding via tail-spike proteins ([@bib103]). Thus, they have been examined as biorecognition elements for pathogen detection using electrochemical biosensors ([@bib146]). Bacteriophages exhibit varying morphologies and are thus classified by selectivity and structure. A variety of bacteriophage-based electrochemical biosensors for pathogen detection can be found in [Table 1](#tbl1){ref-type="table"}. For example, Shabani et al. used *E. coli*-specific T4 bacteriophages for selective impedimetric detection studies ([@bib249]). Mejri et al. compared the use of bacteriophages to antibodies as biorecognition elements for *E. coli* detection ([@bib193]). In that study, they found that bacteriophages improved the water stability of the biosensor and increased the sensitivity by approximately a factor of four relative to the response obtained with antibodies based on EIS measurements ([@bib193]). In another study, Tolba et al. utilized immobilized bacteriophage-encoded peptidoglycan hydrolases on Au screen-printed electrodes for detection of *L. innocua* in pure milk with a LOD of 10^5^ CFU/mL ([@bib275]). These results suggest that bacteriophages are potentially attractive biorecognition elements for water safety and environmental monitoring applications that require chronic monitoring of liquids.

### 2.2.6. Cell- and molecularly-imprinted polymers {#sec2.2.6}

Given traditional biorecognition elements used in biosensing exhibit stability concerns, such as antibodies or aptamers, as discussed in Sections [2.2.1](#sec2.2.1){ref-type="sec"}--2.2.4, there have been efforts to create engineered molecular biorecognition elements, such as scFvs. In contrast, materials-based biorecognition elements exploit the principle of target-specific morphology for selective capture ([@bib209]; [@bib335]). The most common approach in materials-based biorecognition is based on cell- and molecularly-imprinted polymers (CIPs and MIPs, respectively) ([@bib95]). CIPs and MIPs have been created using various processes, including bacteria-mediated lithography, micro-contact stamping, and colloid imprints ([@bib44]; [@bib209]).

As shown in [Fig. 3](#fig3){ref-type="fig"}b, Jafari et al. used imprinted organosilica sol-gel films of tetraethoxysilane and (3-mercaptopropyl)trimethoxysilane (MPTS) for selective detection of *E. coli* using an impedimetric method ([@bib121]). Similarly, Golabi et al. used imprinted poly(3-aminophenylboronic acid) films for detection of *Staphylococcus epidermidis* (*S. epidermidis*) ([@bib91]). Despite the absence of a highly selective molecular biorecognition element, CIPs and MIPs exhibit selectivity when exposed to samples that contain multiple analytes (*i.e.,* non-target species) ([@bib91]; [@bib121]; [@bib223]). MIPs and CIPs are also of interest with regard to opportunities in biosensor regeneration. Common adverse effects of regeneration on biosensors that employ molecular biorecognition elements, such as irreversible changes in structure, are less likely to affect MIPs and CIPs. However, it is generally accepted that current CIPs and MIPs exhibit lower selectivity to target species than antibodies and aptamers due to reduction of available chemical selectivity ([@bib49]; [@bib144]; [@bib314]).

2.3. Immobilization and surface passivation {#sec2.3}
-------------------------------------------

Given biosensors are self-contained devices composed of integrated transducer-biorecognition elements, the immobilization of biorecognition elements on electrodes is central to the design, fabrication, and performance of electrochemical biosensors for pathogen detection. The goal of immobilization is to achieve a stable, irreversible bond between the biorecognition element and the electrode with suitable packing density and orientation that maintains high accessibility and binding affinity to target species. Electrochemical biosensors for pathogen detection have typically used established techniques for preparation of the biorecognition layer. A detailed discussion of immobilization and surface passivation techniques is provided in Supporting Information.

2.4. Thermodynamics of pathogen-biorecognition element binding reactions {#sec2.4}
------------------------------------------------------------------------

While the rate of biosensor response is typically governed by a mass transfer-limited heterogeneous reaction between the immobilized biorecognition element and target species, the net change in the biosensor response is dependent on the reaction thermodynamics. The binding affinity between a biorecognition element and target species, such as an antibody and antigen, is often reported in terms of a dissociation constant (*K* ~*D*~), which has units of M. While the value of *K* ~*D,\ solution*~ = 1 nM provides a reasonable estimate for biosensor design considerations, such as understanding the mass transfer limitations associated with biosensor response ([@bib265]), the binding affinity of antibodies can vary by orders of magnitude depending on the pathogen of interest and the clonality of the antibody. One important consideration when immobilizing biorecognition elements is potential effects of immobilization on binding affinity to the target. Traditionally, *K* ~*D*~ is obtained from a kinetic or thermodynamic analysis. Kinetic analyses measure association and dissociation rate constants (*k* ~*a*~ and *k* ~*d*~, respectively) and enable calculation of *K* ~*D*~ as *k* ~*d*~/*k* ~*a*~. Thermodynamic analyses, such as calorimetric techniques, measure the binding enthalpy and entropy, which in turn provides the standard Gibbs free energy of the reaction (*ΔG*°), and thus, *K* ~*A*~ = *K* ~*D*~ ^−1^ though the expression *K* ~*A*~ = exp(-*ΔG*°/*RT*), where *R* is the gas constant and *T* is the temperature. A detailed discussion of the kinetics and thermodynamics of biorecognition element-target binding reactions for solution- and surface-based biosensors is provided in Supporting Information.

3. Measurement formats for pathogen detection {#sec3}
=============================================

In addition to a physical device composed of an integrated transduction element and biorecognition element, an electrochemical biosensor-based assay for pathogen detection potentially involves processing steps associated with sample preparation and complementary physical systems for biosensor housing and sample handling. The associated protocols for sample preparation and sample handling are often referred to as the measurement format. Several important considerations regarding the measurement format for pathogen detection applications can be considered and vary based on the assay design, the biosensor performance (*e.g.,* sensitivity and LOD), the volume, material properties, and composition of the pathogen-containing sample, and the application. For example, the use of DNA-based assays for pathogen detection typically requires sample preparation steps associated with the extraction of genetic material. Similarly, the use of a label-based biosensing approach requires sample preparation steps associated with target labeling. In cases where the concentration of target species in the sample is below the biosensor\'s LOD, pre-concentration steps may be required. Applications to process monitoring, such in bioreactor or tissue-chip monitoring, may require flow-based sample handling formats. We next discuss the measurement formats associated with pathogen detection in terms of sample preparation and sample handling.

3.1. Sample preparation: Filtration and pre-concentration {#sec3.1}
---------------------------------------------------------

Sample preparation steps have various purposes, including concentrating or amplifying the target species through separation and growth processes, reducing the concentration of background inhibitory species, and reducing the heterogeneity of the sample\'s composition and properties ([@bib337]). We next discuss sample filtration and pre-concentration techniques.

### 3.1.1. Sample filtration {#sec3.1.1}

Generally, sample filtration relies on the principle of size discrepancy between the target pathogen and background species. Membranes, fibers, and channels have been used in size-selective sample filtration processes for biosensing applications. Biorecognition elements are commonly used to assist the separation process when the target species exhibits similar properties to background species or the matrix. For example, biorecognition elements that exhibit affinity to a broad group of pathogens, such as lectins, have been used in pre-concentration steps for pathogen detection ([@bib337]). Bacteria typically exhibit a net negative charge at physiological pH (7.4) because of an abundance of lipopolysaccharides or teichoic acids on the cell membrane (Gram-negative bacteria and Gram-positive bacteria, respectively) ([@bib256]). This physical property of cell-based pathogens is leveraged in biofiltration processes, for example, using electropositive filters ([@bib7]). While the majority of the aforementioned separation processes involve manual handling steps, sample filtration processes are now being integrated with microfluidic-based biosensing platforms ([@bib264]). For example, Chand and Neethirajan incorporated an integrated sample filtration technique using silica microbeads for the detection of norovirus in spiked blood samples ([@bib41]).

### 3.1.2. Centrifugal separation {#sec3.1.2}

Centrifugation can be used as a density gradient-based separation principle for concentrating target pathogens within a sample. In cases where the target species exhibits similar density to background species, the approach is often implemented with antibody-functionalized beads. This technique is commonly employed in applications requiring pathogen detection in complex matrices (*e.g.,* body fluids). Centrifugation-based separation techniques can also potentially be applied to microfluidic-based biosensing platforms. For example, Lee et al. utilized centrifugal microfluidics to process a whole blood sample for subsequent analysis using ELISA ([@bib156]), suggesting that this approach could be extended to electrochemical biosensor-based assays for pathogen detection.

### 3.1.3. Broth enrichment {#sec3.1.3}

Broth enrichment is a technique used to increase the concentration of target species in the sample through growth or replication of target species prior to measurement, thereby increasing the number present for detection. The technique is commonly used in food safety applications. For example, Liebana et al. enriched *S. typhimurium*-spiked milk samples in Luria broth (LB) for 8 h to improve the assay LOD from 7.5 × 10^3^ CFU/mL for the 50-min enriched sample to 0.108 CFU/mL ([@bib165]). Salam et al. enriched fresh chicken samples in enrichment buffer peptone for 18--24 h to recover injured *S. typhimurium* cells for detection via chronoamperometry ([@bib238]). While enrichment can be a useful sample preparation step when the target concentration is below the biosensor\'s LOD, it is inherently limited to viable and cultural organisms. Further, analysis of the results obtained from multiple samples should consider potential differences in the growth rate of bacteria across different samples. It is important to note that the need for sample enrichment significantly increases the TTR and impedes rapid and real-time detection.

### 3.1.4. Magnetic separation {#sec3.1.4}

The separation of the target species from a sample using magnetic beads has become a commonly used sample preparation approach in pathogen detection applications. Target pre-concentration via magnetic bead-based separation processes typically involves the binding of antibody-functionalized magnetic beads to the target species. The bead-target complexes are subsequently separated from the solution by externally-applied magnetic fields. Magnetic-assisted separation processes are useful when the target species exhibits similar properties to other analytes or background species in the sample, such as those with similar size, density, or chemical properties ([@bib47]). The bead-target complexes are then introduced directly to the biosensor to enable quantification of the target pathogen that was present in the initial sample. As shown in [Table 2](#tbl2){ref-type="table"}, magnetic bead-based separation processes have been extensively used for pathogen detection as well as general substrates for traditional immunoassays. Such assays have been used to detect a variety of pathogens, including bacteria, such as *E. coli* ([@bib40] *)* and *Bacillus anthracis* (*B. anthracis*) ([@bib207]), and viruses, such as bovine viral diarrhea virus ([@bib177]) and human influenza A virus ([@bib254]). In addition to serving as a separation agent, magnetic beads also serve as labels.

3.2. Sample handling formats {#sec3.2}
----------------------------

The sample handling format is highly influenced by the biosensor application. As discussed in further detail in the following sections, pathogens are present in liquid and solid matrices and on surfaces (*e.g.,* of biomedical devices). In addition, pathogens can be aerosolized, which is a significant mode of disease transmission associated with viral pathogens (*e.g.,* influenza and COVID-19). Sample handling formats can be generally classified as droplet-, flow-, or surface-based.

Droplet formats involve sampling from a larger volume of potentially pathogen-containing material or fluid. The sample droplet is subsequently analyzed by deposition on a functionalized transducer or transferred to a fluidic delivery system. For example, Cheng et al. created an electrochemical biosensor based on a nanoporous alumina electrode tip capable of analyzing 5 μL of dengue virus-containing solutions ([@bib48]). Droplet formats are simplistic sample handling formats and have the advantage of being performed by unskilled users. While dropletformats have been extensively used with colorimetric biosensors, they have also been adapted for electrochemical biosensors. For example, commercially-available blood glucose meters use a droplet format ([@bib281]). Examples of low-cost, paper-based, or disposable electrochemical biosensors for pathogen detection that utilize droplet formats are provided in [Table 1](#tbl1){ref-type="table"}. For example, Zhao et al. created a screen-printed graphite-based electrode for electrochemical detection of *Vibrio parahaemolyticus* (*V. parahaemolyticus*) based on 5 μL samples ([@bib333]). However, while droplet formats minimize the technical and methodological barriers to measurement, such as eliminating the need for physical systems associated with biosensor housing and sample handling, they can exhibit measurement challenges associated with mass transport and target sampling limitations.

One of the most critical considerations associated with application of droplet formats to pathogen detection is sampling, specifically if sufficient sampling has been performed on the system for which bioanalytical information is desired (*e.g.,* a human, a food source, or source of drinking water). For example, the rationale that the bioanalytical characteristics of a droplet represent that of the bulk system is sound only in a well-mixed system, specifically, a system that exhibits a uniform spatial distribution of species (*i.e.,* concentration profile). We note that while this is typically the case for samples acquired from closed, convective systems, such as body fluids, it should be challenged when considering open systems that exhibit complex flow profiles or regions of static fluid. For example, groundwater systems (*e.g.,* aquifers), rivers, and lakes have been reported to have complex flow profiles ([@bib125]; [@bib332]). Thus, the sampling approach should be considered when examining droplet formats for food and water safety applications. In addition to a consideration of system mixing, one should also consider the potential measurement pitfalls when analyzing samples that contain dilute levels of highly infectious pathogens, such as the potential for false-negative results.

Flow formats involve the detection of target species in the presence of flow fields. Flow formats include continuously-stirred systems (*e.g.,* continuously-stirred tank bioreactors), flow cells, and microfluidics. Flow formats have the advantage of exposing the biosensor to target-containing samples in a controlled and repeatable fashion and the benefit of driving exposure of the functionalized biosensor to target species via convective mass transfer mechanisms. Flow formatsare also typically compatible with large sample volumes (liters). Flow cells are typically fabricated via milling and extrusion processes using materials such as Teflon or Plexiglas. They have the advantage of accommodating a variety of biosensor form factors, such as rigid three-dimensional biosensors. In addition to flow cells, flow formats are commonly achieved using microfluidic devices. While microfluidic devices are typically used with biosensors that exhibit thin two-dimensional form factors, such as planar electrodes, they offer various measurement advantages. Unlike flow cells, which are typically fabricated from machinable polymers, microfluidics are typically fabricated using polydimethylsiloxane (PDMS) and polymethyl methacrylate (PMMA) given their low cost and compatibility with microfabrication approaches. One advantage of microfluidic devices is their ability to perform integrated sample preparation steps, which eliminates the need for additional steps in the sample-to-result process ([@bib258]). For example, microfluidic formats for pathogen detection using electrochemical biosensors have demonstrated fluid pumping, valving, and mixing of small sample volumes ([@bib235]). An example of a microfluidic format created by Dastider et al. for detection of *S. typhimurium* is shown in [Fig. 4](#fig4){ref-type="fig"}a ([@bib61]).

Detection in the presence of flow fields requires high stability of immobilized biorecognition elements ([@bib17]). The effect of flow characteristics on biosensor collection rates is an important consideration, especially when considering micro- and nano-scale transducers with microfluidic formats ([@bib265]). For example, emerging nanostructured electrodes, such as functionalized nanoporous membranes, have been shown to achieve high stability in microfluidic devices ([@bib132]; [@bib271]). A detailed discussion on the relationship between device dimensions, flow characteristics, achievable target collection rates, and equilibrium measurement times has been provided elsewhere ([@bib265]). It is paramount for interpreting biosensor response that users understand the interplay between mass transport of target molecules (both diffusive and convective mechanisms) and reaction at the biosensor surface (*i.e.,* binding of target species to immobilized biorecognition elements). Such fundamental understanding can also be employed in biosensor and experiment design to create improved assay outcomes, such as reducing TTR or improving measurement confidence.

While the presence of pathogens on the surfaces of objects can be analyzed using droplet- and flow-based sample handling formats using material transfer processes, such as swabbing, *in situ* pathogen detection on the object surfaces is a vital measurement capability for medical diagnostic, infection control, and food safety applications. Surface-based measurement formats typically require biosensors with flexible or conforming (*i.e.,* form-fitting) form factors. For example, Mannoor et al. detected the presence of pathogenic species directly on teeth using a flexible graphene-based biosensor ([@bib185]). Further discussion of surface-based pathogen detection applications are provided in the following sections.

The sample handling format often provides insight into the biosensor\'s reusability. Biosensors within the aforementioned measurement formats can be broadly classified as single- or multi-use biosensors. Single-use biosensors are unable to monitor the analyte concentration continuously or upon regeneration, while multiple-use biosensors can be repeatedly recalibrated ([@bib272]). For example, droplet-based low-cost, disposable biosensors for water safety are typically single-use, while biosensors for process monitoring applications can be recalibrated to characterize multiple samples and facilitate continuous monitoring. The ability to regenerate biosensor surfaces following pathogen detection (*i.e.,* remove selectively-bound pathogens) is a significant technical barrier limiting progress in multiple-use biosensors, and industrial applications thereof, and is discussed further in the following sections.

3.3. Electrochemical methods for pathogen detection using electrochemical biosensors {#sec3.3}
------------------------------------------------------------------------------------

Various electrochemical methods can be performed using functionalized electrodes to enable pathogen detection ([@bib17]). These methods differ in electrode configuration, applied signals, measured signals, mass transport regimes, binding information provided ([@bib272]), and target size-selectivity ([@bib9]). Electrochemical methods used for pathogen detection can be classified as potentiometric, amperometric, conductometric, impedimetric, or ion-charge/field-effect, which often signify the measured signal ([@bib272]). The applied signals may be constant or time-varying. The result of the electrochemical method may require analysis of the output signal\'s transient response, steady-steady response, or a combination of both. A detailed discussion of the aforementioned electrochemical methods has been provided elsewhere ([@bib17]). Here, we briefly review the most recent methods employed for pathogen detection using electrochemical biosensors.

### 3.3.1. Potentiometry {#sec3.3.1}

Potentiometric methods, also referred to as controlled-current methods, are those in which an electrical potential is measured in response to an applied current ([@bib17]). The applied current is typically low amplitude. An advantage of controlled-current methods is the ability to use low-cost measurement instrumentation relative to that required for controlled-potential methods.

Hai et al. used potentiometry with a conductive polymer-based biosensor to detect human influenza A virus (H1N1) at a LOD of 0.013 HAU ([@bib101]). Hernandez et al. used potentiometry with a carbon-rod modified electrode that contained reduced graphene oxide to detect *S. aureus* at a single CFU/mL ([@bib107]). Boehm et al. detected *E. coli* via potentiometry utilizing a Pt wire electrode ([@bib30]). Further studies utilizing potentiometric sensing approaches are listed in [Table 1](#tbl1){ref-type="table"}, [Table 2](#tbl2){ref-type="table"}.

### 3.3.2. Voltammetry {#sec3.3.2}

Voltammetric methods, also referred to as controlled-potential methods, are those in which a current is measured in response to an applied electrical potential that drives redox reactions ([@bib17]). The measured current is indicative of electron transfer within the sample and at the electrode surface, and thus, the concentration of the analyte. In chronoamperometry, the electrical potential at the working electrode is applied in steps, and the resulting current is measured as a function of time. The applied electrical potential can also be held constant or varied with time as the current is measured.

Although various types of biosensors are compatible with voltammetry-based measurements, field-effect transistor (FET)-based biosensors often utilize amperometric-based methods for pathogen detection ([@bib116]; [@bib170]). FET biosensors detect pathogens via measured changes in source-drain channel conductivity that arise from the electric field of the sample environment. This is achieved by immobilizing biorecognition elements on the metal or polymer gate electrode of the device. He et al. showed that FETs based on PEDOT:PSS organic electrochemical transistor electrodes enabled the detection of *E. coli* in KCl solutions using Pt and Ag/AgCl gate electrodes ([@bib106]). Wu et al. used a graphene-based FET to detect *E. coli* in nutrient broth diluted with phosphate buffered saline solution with amperometry using a Ag/AgCl gate electrode ([@bib306]).

Further examples of amperometric sensing include the detection of human influenza A virus by Singh et al. using a reduced graphene oxide-based electrode and chronoamperometry using Fe(CN)~6~ ^3^ ^-^ ^/4-^ at a LOD of 0.5 plaque-forming units (PFU)/mL ([@bib262]). Lee and Jun utilized wire-based electrodes for amperometric detection of *E. coli* and *S. aureus* ([@bib158]). A detailed list of studies that utilize amperometric methods for pathogen detection is provided in [Table 1](#tbl1){ref-type="table"}, [Table 2](#tbl2){ref-type="table"}

#### 3.3.2.1. Linear sweep and cyclic voltammetry {#sec3.3.2.1}

Linear sweep voltammetry (LSV) methods are those in which a current is measured in response to an applied electrical potential that is swept at a constant rate across a range of electrical potentials ([@bib17]). Cyclic voltammetry (CV) is a commonly used linear-sweep method in which the electrical potential is swept in both the forward and reverse directions in partial cycles, full cycles, or a series of cycles. CV is one of the most widely used voltammetric methods for pathogen detection.

Hong et al. used sweep voltammetry to detect norovirus in a sample solution with Fe(CN)~6~ ^3^ ^-^ ^/4-^ extracted from lettuce ([@bib110]). A typical CV response using Fe(CN)~6~ ^3^ ^-^ ^/4-^ associated with pathogen detection is shown in [Fig. 5](#fig5){ref-type="fig"} a for various concentrations of *E. coli* binding to a polymer composite electrode ([@bib97]). A detailed overview of pathogen detection studies based on CV is provided in [Table 1](#tbl1){ref-type="table"}, [Table 2](#tbl2){ref-type="table"}.Fig. 5Typical responses associated with the common electrochemical methods used for pathogen detection. **a**) Cyclic voltammetry (CV) data using Fe(CN)~6~^3-/4-^ for varying concentrations of *E. coli* ([@bib97]). **b**) Differential pulse voltammetry (DPV) data using Fe(CN)~6~^3-/4-^ for varying concentrations of *S. aureus* ([@bib27]). **c**) Electrochemical impedance spectroscopy (EIS) in 100 mM LiClO~4~ solution in the form of a Nyquist plot and corresponding equivalent circuit model associated with biorecognition element immobilization and detection of *S. typhimurium* ([@bib253]). **d**) Conductometry data for varying concentrations of *B. subtilis* ([@bib323]).Fig. 5

#### 3.3.2.2. Pulse voltammetry {#sec3.3.2.2}

Pulse voltammetry is a type of voltammetry in which the electrical potential is applied in pulses. The technique has the advantage of improved speed and sensitivity relative to traditional voltammetric techniques ([@bib17]; [@bib197]). In staircase voltammetry, the electrical potential is pulsed in a series of stair steps and the current is measured following each step change, which reduces the effect of capacitive charging on the current signal. Square wave voltammetry (SWV) is a type of staircase voltammetry that applies a symmetric square-wave pulse superimposed on a staircase potential waveform. The forward pulse of the waveform coincides with the staircase step. In differential pulse voltammetry (DPV), the electrical potential is scanned with a series of fixed amplitude pulses and superimposed on a changing base potential. The current is measured before the pulse application and again at the end of the pulse, which allows for the decay of the nonfaradaic current ([@bib246]).

For example, Iqbal et al. used SWV with AuNP-modified carbon electrodes for detection of *C. parvum* in samples taken from fruit ([@bib120]). Kitajima et al. also used SWV with Au microelectrodes to detect norovirus at a LOD of 10 PFU/mL ([@bib138]). Cheng et al. used DPV and a nanostructured alumina electrode for detection of dengue type 2 virus with a LOD of 1 PFU/mL ([@bib48]). As shown in [Fig. 5](#fig5){ref-type="fig"}b, Bhardwaj et al. used DPV with a carbon-based electrode to detect *S. aureus* ([@bib27]). Additional studies that utilize pulse voltammetry methods forpathogen detection are listed in [Table 1](#tbl1){ref-type="table"}, [Table 2](#tbl2){ref-type="table"}.

#### 3.3.2.3. Stripping voltammetry {#sec3.3.2.3}

Many of the previously described voltammetric methods can be modified to include a step that pre-concentrates the target on the electrode surface. Subsequently, the pre-concentrated target is stripped from the surface by application of an electrical potential. In anodic stripping voltammetry (ASV), a negative potential is used to pre-concentrate metal ions onto the electrode surface. These ions are then stripped from the surface by applied positive potentials. Although most commonly used to detect trace amounts of metals, this method has been adapted for pathogen detection by electrocatalytically coating metallic labels on bound targets for oxidative stripping and subsequently measuring the current response ([@bib1]).

Chen et al. used stripping voltammetry with a polymer-CNT composite-based electrode to detect *E. coli* at a LOD of 13 CFU/mL ([@bib43]). In that study, the biosensor was first incubated with *E. coli*. Silica-coated Ag nanoparticles conjugated with anti-*E.coli* were subsequently introduced to the system, inducing a binding reaction between the bacteria and the nanoparticles. After rinsing non-specifically bound particles, acid was introduced to dissolve Ag(s), and the resulting Ag^+^-rich solution was characterized using DPV. Viswanathan et al. used ASV with screen-printed composite electrodes for multiplexed detection of *Campylobacter*, *S. typhimurium*, and *E. coli* with a LOD of 400 cells/mL, 400 cells/mL, and 800 cells/mL, respectively ([@bib284]). In that study, antibody-functionalized nanocrystalline bioconjugates were first introduced to biosensor-bound bacteria, the specifically bound particles were dissolved with acid, and the ions were then stripped using a square-wave voltammetric waveform. Additional studies using stripping voltammetry for electrochemical detection of pathogens can be found in [Table 1](#tbl1){ref-type="table"}, [Table 2](#tbl2){ref-type="table"}.

### 3.3.3. Electrochemical impedance spectroscopy {#sec3.3.3}

The aforementioned electrochemical methods involved responses based on step changes or continuous sweeps in the applied current or voltage that drove the electrode to a condition far from equilibrium. Alternatively, frequency response methods, often referred to as impedance-based or impedimetric methods, are based on frequency response analysis (*i.e.,* the response of the system to periodic applied current or potential waveforms at either a fixed frequency or over a range of frequencies) ([@bib17]). This provides several advantages, including measurement over a wide range of times and frequencies and high precision in time-averaged responses. We next discuss impedance-based electrochemical methods for detection of pathogens using electrochemical biosensors.

In EIS the impedance and phase angle of the system are measured as a function of the frequency of the applied electrical potential. EIS is a diverse electrochemical method, which can be done as a faradaic or non-faradaic process, and enables the study of intrinsic material properties, experiment-specific processes, or biorecognition events at the electrode surface. EIS is often performed using an applied low-amplitude sinusoidal electrical potential and a three-electrode configuration. Equivalent circuit models are commonly fit to experimental impedance and phase angle data to interpret the electrochemical process in terms of passive circuit elements, such as resistors and capacitors. For example, the electric double layer is typically modeled as a capacitive element, while the resistance to faradaic charge transfer at the electrode-electrolyte interface is represented as a resistor, often referred to as the charge transfer resistance. Additional circuit elements, such as constant-phase or Warburg elements, can also be included to represent other features of the electrochemical cell and process, such transport characteristics of the species at the electrode-electrolyte interface. The Randles model is a commonly used equivalent circuit for interpretation of biosensor EIS data. The circuit consists of an electrolyte resistance in series with a parallel combination of the double-layer capacitance with the charge transfer resistance and the Warburg impedance element ([@bib225]). Variations of this model have been formulated for a variety of biosensing studies. For example, the equivalent circuit model and associated Nyquist plot for electrochemical detection of *S. typhimurium* using EIS with a poly(pyrrole-co-3-carboxyl-pyrrole) copolymer supported aptamer can be found in [Fig. 5](#fig5){ref-type="fig"}c ([@bib253]). The equivalent circuit model consists of the solution resistance, charge transfer resistance at the copolymer-aptamer/electrolyte interface, and constant phase element for the charge capacitance at the copolymer-aptamer/electrolyte interface ([@bib253]).

While the impedance can be measured across a range of frequencies and interpreted using equivalent circuit models that describe impedance response over a wide frequency range, fixed-frequency measurements are also useful for biosensing applications. Fixed-frequency measurements are typically based on the identification of single frequencies or small frequency ranges in the impedance spectra that are most sensitive to molecular binding events. Fixed-frequency approaches have the advantage of increasing the sampling frequency of the biosensor. As a result, impedance-based electrochemical methods generate biosensor responses in terms of changes in the measured physical quantities (*e.g.,* changes in impedance) or calculated equivalent circuit elements (*e.g.,* double-layer capacitance or charge-transfer resistance).

As shown in [Table 1](#tbl1){ref-type="table"}, [Table 2](#tbl2){ref-type="table"}, EIS is one of the most commonly used methods for electrochemical detection of pathogens. For example, Zarei et al. used EIS with an Au nanoparticle-modified carbon-based electrode for detection of *Shigella dysenteriae* (*S. dysenteriae*) at a LOD of 1 CFU/mL ([@bib325]). Primiceri et al. used EIS with Au interdigitated microelectrode arrays and Fe(CN)~6~ ^3^ ^-^ ^/4-^ to detect *L. monocytogenes* at a LOD of 5 CFU/mL ([@bib221]). Andrade et al. used EIS with a CNT-based electrode for multiplexed detection of *E. coli*, *B. subtilis*, and *Enterococcus faecalis* ([@bib10]).

Redox reactions at the electrode-electrolyte interface are typically established using a redox probe. Owing to its high reversibility, the Fe(CN)~6~ ^3^ ^-^ ^/4-^ redox couple has been widely investigated as an electrochemical probe for biosensing applications and is regarded as a standard model for highly reversible electrochemical reactions ([@bib62]). While useful electrochemical probes, redox reactions may also affect the electrode and immobilized biorecognition elements. For example, redox reactions associated with the Fe(CN)~6~ ^3^ ^-^ ^/4-^ probe can cause etching of Au electrodes due to the presence of CN^−^ ions when using the redox couple for EIS measurements ([@bib285]). This observation warrants further investigation, particularly in the context of establishing the effects on biosensor repeatability and reusability. The use of alternative redox probes or electrode materials may mitigate such effects. For example, ferrocene and ferrocenemethanol have also been used as redox probes for pathogen detection. Ruthenium(III)/ruthenium(II) ([@bib244]) and immobilized quinone pairs ([@bib219]) are also potentially useful alternatives.

Biosensors that use impedance-based methods and whose impedance response can be modeled using equivalent circuit models can be used to calculate the capacitance of the electric double layer. The double-layer capacitance is recognized to be sensitive to the structure of the electrode, the characteristics and concentration of analytes at the electrode surface and in the electrolyte, and the characteristics of the electrolyte ([@bib168]). As a capacitor, the double-layer is not only dependent on the dielectric material but also the thickness of the dielectric layer. Importantly, both characteristics could be affected by molecular binding events on an electrode. For example, when a target analyte binds to an immobilized biorecognition element, counter ions around the electrode surface are displaced, leading to a change in the capacitance ([@bib25]). The capacitance can be determined from the reactive component of the impedance or by fitting of an equivalent circuit model ([@bib21]).

Idil et al. used the capacitive response of a MIP electrode for the detection of *E. coli* ([@bib119]). Jantra et al. similarly used the capacitive response of an Au rod electrode for the detection of *E. coli* ([@bib124]). Luka et al. used the capacitive response of an Au interdigitated microelectrode array based on equivalent circuit analysis for the detection of *C. parvum* ([@bib174]). See [Table 1](#tbl1){ref-type="table"}, [Table 2](#tbl2){ref-type="table"} for a detailed list of studies that have used the capacitive response of an electrochemical biosensor for pathogen detection.

### 3.3.4. Conductometry {#sec3.3.4}

Conductometry methods are those in which the conductivity of the sample solution is monitored using a low-amplitude alternating electrical potential ([@bib73]). The principle relies on conductivity change in the sample via the production or consumption of charged species. The measurement has the advantage of not requiring a reference electrode and can be used to detect both electroactive and electroinactive analytes ([@bib122]; [@bib201]). Given the method can be performed using a two-electrode configuration, conductometric biosensors can be easily miniaturized. In addition, they are less vulnerable to many types of interference due to their differential measurement mode ([@bib122]).

As shown in [Fig. 5](#fig5){ref-type="fig"}d, Yoo et al. used a conductometric biosensor with CNT-based electrodes for the detection of *B. subtilis* ([@bib323]). Mannoor et al. used a previously described conductometric biosensor to detect *S. aureus* and *Helicobacter pylori* on tooth enamel ([@bib185]). Shen et al. detected two strains of human influenza A virus (H1N1 and H3N2) using conductometry with a silicon nanowire array at a LOD of 29 viruses/μL ([@bib254]). Additional studies that have examined the use of conductometric biosensors for pathogen detection can be found in [Table 1](#tbl1){ref-type="table"}, [Table 2](#tbl2){ref-type="table"}.

3.4. Secondary binding approaches {#sec3.4}
---------------------------------

Electrochemical biosensors would ideally produce sensitive and selective results using label-free protocols. However, secondary binding reactions are sometimes required to facilitate the robust detection of pathogens that lack initial labels depending on the biosensor characteristics and measurement demands. Secondary binding steps can facilitate target labeling, biosensor signal amplification, and verification of target binding. Secondary binding steps provide useful *in situ* controls and can increase sensitivity, LOD, dynamic range, and measurement confidence (*e.g.,* verification of target binding). Secondary binding steps also provide opportunities for acquiring additional bioanalytical information about the target species.

Here, we classify assays that use secondary binding steps as labeled approaches in [Table 1](#tbl1){ref-type="table"}, [Table 2](#tbl2){ref-type="table"} regardless of if the primary binding step produced a response. There is, however, a more subtle distinction if binding of the secondary species is used for amplification or verification purposes as previously discussed. Labels often include a biorecognition element-enzyme or -nanoparticle conjugate. In electrochemical biosensing applications, such labels often serve the purpose of altering the material properties or transport processes of the electrode-electrolyte interface, often by inducing a secondary reaction. Secondary binding of optically-active nanomaterials to captured targets can also enable the use of optical transducers for simultaneous detection or bioanalysis. Enzymes are among the most commonly used secondary binding species for label-based pathogen detection. As shown in [Table 2](#tbl2){ref-type="table"}, electrochemical biosensors for pathogen detection that employ enzymes are commonly performed as a sandwich assay format. A schematic of secondary binding steps for biosensor amplification based on the binding of HRP-antibody conjugates is shown in [Fig. 6](#fig6){ref-type="fig"} a ([@bib141]). Hong et al. used HRP-labeled secondary antibodies to amplify the CV and EIS responses of a concanavalin A-functionalized nanostructured Au electrode to detect norovirus ([@bib110]). Gayathri et al. used an HRP-antibody conjugate to induce an enzyme-assisted reduction reaction with an immobilized thionine-antibody receptor in an H~2~O~2~ system for detection of *E. coli* down to 50 CFU/mL using a sandwich assay format ([@bib87]). Xu et al. used glucose oxidase and monoclonal anti-*S. typhimurium* to functionalize magnetic bead labels for separation and detection of *S. typhimurium* on an Au IDAM using EIS and glucose to catalyze the reaction that exhibited a linear working range of 10^2^ to 10^6^ CFU/mL ([@bib311]).Fig. 6Highlight of secondary binding and signal amplification approaches utilized in electrochemical biosensor-based pathogen detection. **a**) Four amplification approaches associated with the secondary binding of enzyme-labeled secondary antibodies: (A) electron transfer mediation; (B) nanostructuring of surface for increased rate of charge transfer kinetics; (C) conversion of electrochemically inactive substrate into a detectable electroactive product; (D) catalysis of oxidation of glucose for production of hydrogen peroxide for electrochemical detection ([@bib141]). **b**) Signal amplification via non-selective binding of AuNPs to bound bacterial target (*E. coli*) ([@bib287]).Fig. 6

In addition to enzymes, secondary binding of nanoparticles has also been used for pathogen detection. As shown in [Fig. 6](#fig6){ref-type="fig"}b, Wan et al. utilized non-functionalized AuNPs to amplify the EIS response of an antibody-immobilized planar Au electrode to *E. coli* detection ([@bib287]). A detailed overview of studies that employ enzymes and nanoparticles is provided in [Table 2](#tbl2){ref-type="table"}. We remind the reader that while secondary binding steps are useful techniques, assays that avoid secondary binding steps have advantages for bioprocess monitoring and control applications, as they avoid the addition of reagents to a process that may compromise product quality).

4. Applications to pathogen detection {#sec4}
=====================================

As identified in the previous sections, the application influences the biosensor design and measurement format associated with a given electrochemical biosensor-based assay for pathogen detection. We next review applications of electrochemical biosensors for pathogen detection in food and water safety, environmental monitoring and infection control, medical diagnostics, and bio-threat defense.

4.1. Food and water safety applications {#sec4.1}
---------------------------------------

Detection of foodborne and waterborne pathogens is an essential aspect of public healthcare. Foodborne and waterborne pathogens originate from a variety of sources and matrices and typically infect humans through the consumption of contaminated food and water. Waterborne pathogens are responsible for about 2.2 million deaths annually worldwide ([@bib211]), and contaminated food-related deaths amount to around 420,000 annually ([@bib301]). In 2019, the United States suffered an outbreak of multidrug-resistant *S. typhimurium* in turkey products caused 358 infections across 42 states, demonstrating the importance of detecting pathogens in food sources ([@bib38]).

While biosensors for pathogen detection are critical to water and food safety in developed regions, biosensors are particularly important aspects of public healthcare in remote and under-developed regions due to relatively reduced infrastructure and resources for food and water quality analysis. For example, in 2014, a cholera outbreak linked to *V. cholerae* in Ghana, which has been associated with poor environmental water management and sanitation issues, infected over 20,000 individuals ([@bib205]). The selective detection of pathogens in food and water remains a global healthcare challenge. Several comprehensive reviews have been written on biosensors for food and water safety ([@bib15]; [@bib31]; [@bib159]; [@bib320]). Here, we describe the most common foodborne and waterborne pathogens. Common foodborne and waterborne pathogens include protozoa, such as *C. parvum* and *G. lamblia*, bacteria, such as *E. coli*, *L. monocytogenes*, *S. typhimurium*, *S. aureus*, and *Campylobacter,* and viruses, such as norovirus and rotavirus ([@bib26]; [@bib34]).

The infectious dose of foodborne and waterborne pathogens can vary by 4--6 orders of magnitude, from a single cell or oocyst to greater than one million cells. For example, the infectious dose of *S. dysenteriae* is 200 CFU ([@bib94]), while that of *S. aureus* is 100,000 CFU ([@bib243]). Given the extensive use of immunoassays in food and water safety, such as ELISA, it is possible to obtain commercially-available monoclonal and polyclonal antibodies for a large number of foodborne and waterborne pathogens.

Biosensor applications associated with process monitoring applications may require biosensor designs and measurement formats that facilitate high-throughput analysis, continuous monitoring capability, and biosensor reusability. Alternatively, those for water safety applications in under-developed regions may require biosensor designs and measurement formats that facilitate field use, such as sample preparation-free protocols. Pathogens can also enter food and water through processing, packaging, distribution, and storage processes (*e.g.,* via workers and pests) ([@bib26]; [@bib192]; [@bib320]). As a result, biosensors for food and water safety applications should facilitate pathogen detection at various stages of the processing operation. Recent advances in electrochemical biosensors for food and water safety applications have established new low-cost biosensor designs, portable measurement formats, and flexible form-factors and are discussed further in the following sections.

4.2. Environmental monitoring and infection control applications {#sec4.2}
----------------------------------------------------------------

In addition to foodborne and waterborne pathogens, the detection of environmental pathogens is also an important aspect of healthcare. For example, diseases associated with environmental pathogens are one of the leading causes of death in low-income economies ([@bib302]). For example, malaria was reported to cause an estimated 435,000 deaths in 2017 ([@bib303]). Environmental pathogens are microorganisms that typically spend a substantial part of their lifecycle outside human hosts, but when introduced to humans through contact or inhalation cause disease with measurable frequency. Thus, environmental pathogens are often targets in medical diagnostics applications. However, here, we choose to distinguish environmental monitoring applications, which require pathogen detection in the environment (*e.g.,* in air or on surfaces), from medical diagnostics applications, which require detection in body fluids. Thus, the distinction is based on the matrix in which the pathogen is present. Similar to food and water safety applications, which require biosensors capable of analyzing pathogen-containing complex matrices, such as a water or food matrix, environmental pathogens are present in multiple types of matrices. While environmental pathogens can enter the body through direct physical contact, they can also be transmitted through aerosols or interaction with organisms that serve as vectors for the infectious agent, such as mosquitos in the case of *Plasmodium falciparum* (the infectious agent associated with malaria). Thus, the detection of environmental pathogens often requires analysis of matrices, such as air, and objects, such as the surfaces of biomedical devices or objects within healthcare facilities, that are present in the human environment ([@bib149]).

Several comprehensive reviews have been provided on the detection of environmental pathogens ([@bib15]; [@bib134]). Here, we describe the most common environmental pathogens found both in and outside of clinical settings. Common environmental pathogens in a non-clinical setting include Legionella spp., which cause Legionnellosis, *Mycobacterium tuberculosis*, which causes tuberculosis, and Naegleria fowleri, which causes amoebic meningitis. In addition to bacteria and protozoa, fungi, nematodes, and insects are also environmental pathogens. Common environmental pathogens in clinical settings associated with healthcare-acquired infections include drug-resistant and multi-drug resistant (MDR) pathogens, such as *Clostridium difficile* (CD) ([@bib111]), which causes CD-associated diarrhea and antibiotic-induced colitis, and methicillin-resistant *S. aureus* (MRSA), which causes severe infections in various parts of the body, including the urinary tract ([@bib93]).

The infectious dose of environmental pathogens also varies by orders of magnitude depending on the pathogen as well as age and health of the individual. For example, the infectious dose of CD is less than 10 spores, while that of MRSA is greater than 100,000 organisms ([@bib243]). While it is possible to obtain antibodies for foodborne and waterborne pathogens, it can be challenging to obtain antibodies for various environmental pathogens, including protozoa and nematodes. Thus, traditional bioanalytical techniques, such as PCR, are often utilized for the detection of environmental pathogens.

Similar to food and water safety applications, biosensor-based assays for environmental pathogen detection applications also utilize measurement formats that facilitate the analysis of liquids. However, they also require measurement formats for the detection of aerosolized pathogens. In addition to airborne transmission, environmental pathogens are transmitted by direct surface contact (similar to many foodborne pathogens), which is a significant mode of transmission in healthcare settings (*e.g.,* of healthcare-acquired infections). Standardized guidelines for disinfecting and sterilizing the surfaces of medical equipment, assistive technologies, counters, and doors, among other surfaces, have emerged as an important aspect of infection control in modern healthcare facilities ([@bib84]). Thus, the detection of pathogens on the surfaces of biomedical devices and objects present in healthcare facilities is an important research area ([@bib143]; [@bib298]). For example, bacterial contamination of inanimate surfaces and equipment has been examined as a source of intensive care unit-acquired infections, a global healthcare challenge, especially when caused by MDR pathogens ([@bib237]). Hospital-acquired infections are prevalent causes of morbidity in patients ([@bib206]). This problem has only been exasperated by the rise of MDR CD*,* as well as drug-resistant strains of *Campylobacter, Enterococcus, Salmonella, S. aureus,* and *S. dysenteriae* ([@bib282]). In addition to clinical pathogens, it is also of interest to detect pathogens in non-clinical settings ([@bib81]). Toxin-producing algae, such as cyanobacteria and sulphate-reducing bacteria, are also important targets for electrochemical biosensors associated with the prevention of water-based diseases.

4.3. Medical diagnostic applications {#sec4.3}
------------------------------------

The field of medical diagnostics heavily relies on the identification and quantification of pathogens found in body fluids, including whole blood, stool, urine, mucus, saliva, or sputum. Diagnostic assays based on traditional bioanalytical techniques for detection of pathogens in body fluids are the gold standard and serve an essential role in healthcare by enabling the diagnosis and treatment of various diseases. Biosensors offer a complementary diagnostic platform that enable rapid and cost-effective measurements, high sensitivity, and the ability to make measurements in complex matrices that pose challenges to traditional bioanalytical techniques. Studies suggest that rapid diagnostic testing can potentially reduce the chance of hospitalization, duration of hospitalization and antimicrobial use, and mortality rates ([@bib18]; [@bib23]; [@bib66]; [@bib228]). For example, repeated rapid screening programs for human immunodeficiency virus (HIV) detection is recommended as a means of increasing quality-adjusted life years of health for citizens in the United States ([@bib208]). Additionally, the need for rapid antibody screening has been identified as an important aspect of mitigating the ongoing COVID-19 pandemic.

Several comprehensive reviews have been published on traditional bioanalytical assays and biosensor-based assays for pathogen detection in medical diagnostics applications ([@bib4]; [@bib58]; [@bib261]). Common pathogens include the aforementioned foodborne, waterborne, and environmental pathogens (*e.g., Mycobacterium* and Plasmodium spp.), as well as additional airborne and bloodborne pathogens. Pathogens such as *Mycobacterium*, HIV, and Plasmodium falciparum, represent some of the top causes of death from infectious diseases worldwide ([@bib302]). Other common pathogens associated with medical diagnostics applications include those that cause respiratory infections, urinary tract infections, and diarrheal diseases, such as CD and MRSA, which can be life-threatening to the children, elderly and individuals with compromised immune systems. Other airborne and bloodborne pathogens of interest include the influenza virus, COVID-19, hepatitis virus, rabies virus, and bacteria such as *Mycoplasma pneumonia* and *Bordetella pertussis*.

The infectious dose of airborne and bloodborne pathogens also varies by orders of magnitude depending on the pathogen, the method of contraction, and the age and health of the individual. For example, the infectious dose of influenza is between 100--1000 particles ([@bib100]), while the median infectious dose of HIV can vary, for example, from two RNA copies to 65,000 depending on the strain and source ([@bib230]).

The diagnostically-relevant concentration of pathogens in each type of matrix must be considered when designing a biosensor for pathogen detection. For example, the detection of bacteria in blood versus urine exhibit different diagnostic thresholds ([@bib136]). Such knowledge can inform the need for sample preparation steps.

4.4. Biological defense and bio-threat applications {#sec4.4}
---------------------------------------------------

The potential for the weaponization of pathogens drives the need for rapid and sensitive biosensors for biological defense applications. Biosensor applications to biological defense and bio-threat are related to the aforementioned applications in food and water safety, environmental monitoring, and medical diagnostics but consider weaponized pathogens. However, while pathogens found in environmental monitoring applications are often native and endogenous agents, pathogens found in biological defense and bio-threat applications are often exogenous agents, which may have been weaponized and intentionally dispersed. For example, pathogen-based bio-threat situations typically involve the overt or covert introduction of an exogenous pathogen into either the food or water supply or environments which with humans closely interact ([@bib54]; [@bib195]; [@bib250]).

The reader is directed to various comprehensive reviews on biosensor-based assays for the detection of biowarfare agents ([@bib53]; [@bib250]). Common targets include the aforementioned airborne pathogens. In addition to the aforementioned naturally-occurring pathogens, pathogens for bio-threat may include engineered pathogens, such as genetically-modified viruses that can be transmitted via airborne pathways. *B. anthracis* (Anthrax), *yersinia pestis* (plague), and vaccinia virus are among several pathogens that have been utilized or suggested as biowarfare agents ([@bib53]; [@bib250]).

While pathogen-based bio-threats may be introduced to the water and food supply, the detection of pathogen-based bio-threats in air is particularly critical to biowarfare defense, as they may be introduced into the battlefield in the form of aerosols. Further, the dispersal of pathogen-based bio-threats by air in facilities (*e.g.,* via air-handling systems) represents a significant domestic bioterrorism concern. Thus, biosensor-based assays for bio-threat applications should be low-cost and portable to enable integration with existing physical systems (*e.g.,* facilities) and movement with the warfighter or drones on the battlefield. Having discussed transduction elements, biorecognition elements, electrochemical methods, measurement formats, and pathogen detection applications, we next discuss the present challenges and future directions in the field of electrochemical biosensor-based pathogen detection.

5. Present challenges and future directions for pathogen detection using electrochemical biosensors {#sec5}
===================================================================================================

Here, we discuss the present challenges and future directions associated with pathogen detection using electrochemical biosensors to identify future research opportunities and emerging areas in the field.

5.1. Emerging electrode materials, fabrication processes, and form factors {#sec5.1}
--------------------------------------------------------------------------

The ability to create robust, low-cost biosensors for pathogen detection is a significant challenge in the field. One of the primary methods of reducing cost is decreasing the material cost per device. Carbon-based electrodes (*e.g.,* graphite, graphene, CNTs), such as those shown in [Fig. 7](#fig7){ref-type="fig"} a ([@bib3]) and 7b ([@bib297]), are now being examined as potential alternatives to relatively more expensive metallic or ceramic electrodes. Many of these carbon-based materials are also nanoscale in structure, and thus offer advantages regarding nanostructuring. Similarly, polymer-based electrodes have also been examined as low-cost alternatives to metal electrodes as described in Section [2.1.3](#sec2.1.3){ref-type="sec"}. For example, Afonso et al. used a home craft cutter printer as a highly accessible means of fabricating high quantities of disposable carbon-based sensors ([@bib3]).Fig. 7State-of-the-art developments in electrochemical biosensors for pathogens. **a**) Low-cost, flexible, disposable screen-printed carbon electrodes ([@bib3]). **b**) Free-standing graphene electrodes ([@bib297]). **c**) Paper-based substrates for pathogen detection using electrochemical methods ([@bib27]). **d**) Wearable wireless bacterial biosensor for tooth enamel ([@bib185]). **e**) Smartphone-enabled signal processing for field-based environmental monitoring ([@bib127]).Fig. 7

In addition to reducing the material cost per device, efforts to reduce the manufacturing cost of biosensors have also been examined. 3D printing processes have emerged as popular methods for biosensor fabrication. For example, 3D printing is compatible with flexible and curved substrates. 3D printing has also been used for the fabrication of various components of electrochemical biosensors, such as electrodes, substrates, fluid handling components, or device packaging. In particular, 3D printing has emerged as a useful fabrication platform for microfluidic-based analytical platforms ([@bib286]). For example, to date, 3D printing has enabled the fabrication of electrode-integrated microfluidics ([@bib75]), 3D microfluidics, organ-conforming microfluidics ([@bib260]), and transducer-integrated microfluidics ([@bib39]). Thus, 3D printing may serve as an important fabrication platform for the creation of wearable microfluidic-based electrochemical biosensors for pathogen detection.

The ability to quantify the level of pathogens on the surfaces of objects (*e.g.,* skin, food, and medical equipment) remains a present challenge in the biosensing field. Wearable biomedical devices have emerged as promising tools for point-of-care (POC) diagnostics and health monitoring. The application constraints of wearable devices require them to be lightweight and simple to operate. Wearable devices can provide continuous monitoring of body fluids, such as blood and sweat, allowing patients to obtain real-time bioanalytical information without the inconvenience of facility-based screening. To date, biosensors have been incorporated into a variety of wearable devices, including contact lenses, clothing, bandages, rings, and tattoos ([@bib16]). This is a rapidly emerging area linked to smartphone technology for biosensor actuation and monitoring. The rise of flexible electronics has also contributed to the success of incorporating electrochemical biosensors into flexible textiles, which has enhanced their wearability ([@bib234]). Although most wearable electrochemical biosensors are used to detect small molecules, such as lactate, glucose, or electrolytes, there is increasing interest in their application to pathogen detection. Challenges include biocompatibility (*e.g.,* reduction of skin irritation), device power consumption, and biosensor-tissue mechanical and geometric matching. Because of the small sample size of body fluid secretions and the need to transport the sample to the electrode surface, microfluidic formats are now emerging for wearable bioanalytical systems ([@bib260]).

5.2. Detection of protozoa {#sec5.2}
--------------------------

Importantly, the size of the pathogen may have a significant impact on a given electrochemical biosensor\'s performance based on the type of electrochemical method used. For example, pathogens can range greater than three orders of magnitude in size. For example, the diameter of norovirus was estimated at 27 nm ([@bib236]), while the diameter of *G. lamblia* oocysts is \~14 μm ([@bib2]). Electrochemical biosensors for the detection of protozoa-based pathogens is an area requiring further attention. Protozoa, as large pathogens, achieve relatively less coverage of the electrode than small pathogens, thereby having a relatively smaller effect on charge transfer at the electrode-electrolyte interface. *C. parvum* is at present the most commonly detected protozoa using electrochemical biosensors (see [Table 1](#tbl1){ref-type="table"}) ([@bib120]) ([@bib174]).

5.3. Detection of plant pathogens {#sec5.3}
---------------------------------

While the majority of infectious agents detected using electrochemical biosensors are human pathogens, emerging agricultural applications of electrochemical biosensors, such as in smart agriculture, suggest the need for biosensors capable of detecting plant pathogens ([@bib137]). For example, crop yield losses associated with plant pathogens range from 8.1 to 41.1% based on global production of wheat, rice, maize, potato, and soybean ([@bib241]). Common plant pathogens include viruses, viroids, bacteria, fungi, and oomycetes. Chartuprayoon et al. recently established a polypyrrole nanoribbon-based chemiresistive immunosensor for detection of viral plant pathogens ([@bib42]).

5.4. Multiplexed detection {#sec5.4}
--------------------------

Multiplexed detection of pathogens has emerged as a technique for phenotype identification and identification of multiple pathogenic threats. Multiplexing can be achieved via various approaches, but typically involves the use of multiple transducers that exhibit different biorecognition elements. For example, a strategy for multiplexed bacterial detection by Li et al. via immobilization of anti-*E. coli* and anti-*V. cholerae* on AuNPs is shown in [Fig. 4](#fig4){ref-type="fig"}b ([@bib163]). Spatially-distributed biorecognition elements on a single electrode or multiple electrodes can also provide multiplexing capability. For example, a strategy based on the immobilization of anti-*E. coli* and anti-*S. aureus* within a microfluidic chamber created by Tian et al. is shown in [Fig. 4](#fig4){ref-type="fig"}c ([@bib273]).

5.5. Saturation-free continuous monitoring formats {#sec5.5}
--------------------------------------------------

The inability to regenerate biosensors is a major hindrance to biosensor-based process monitoring and control applications. While various biosensors must be disposed of after a single use, the regeneration of biosensor surfaces using chemical approaches has been leveraged as an approach for creating multiple-use biosensors. Biosensor regeneration approaches typically involve chemically-mediated dissociation of the target from the immobilized biorecognition element or removal of the biorecognition element altogether. This can be accomplished through acid-base mediated regeneration, detergents, glycine, and urea as well as achieved by thermal regeneration, plasma cleaning, or even direct electrochemical desorption ([@bib92]; [@bib115]; [@bib326]). For example, Dweik et al. used a combination of organic (acetone) and plasma cleaning protocols to regenerate an Au interdigitated microelectrode array after detection of *E. coli* to use devices five times each ([@bib71]). Johnson and Mutharasan used a liquid-phase hydrogen peroxide-mediated UV-photooxidation process for regeneration of biosensor surfaces as an alternative to aggressive chemical treatments, such as those based on the use of high- or low-pH solutions ([@bib130]). We note that an ideal biosensor regeneration (*i.e.,* cleaning) approach for process monitoring applications would remove the captured target *in situ* using a chemical-free approach and preserve the biorecognition layer for subsequent measurements.

5.6. Low-cost, single-use portable biosensors {#sec5.6}
---------------------------------------------

The creation of environmentally-friendly disposable substrates is a present challenge for low-cost single-use biosensors. Paper-based substrates have recently emerged as attractive alternatives to costlier ceramic substrates ([@bib189]). Paper-based substrates can also eliminate the need for supporting fluid handling components through capillary effects. For example, paper substrates can be patterned with hydrophobic and hydrophilic regions to direct fluid flow ([@bib37]). Paper-based devices are also relatively environmentally friendly in terms of material sourcing, disposal, and degradation. However, the potential toxicity of materials that may have been deposited on paper substrates, such as nanomaterials, should still be considered when assessing the environmental impact of a disposable single-use biosensing platform. For example, the long-term environmental and health impacts of nanomaterials remain active areas of research ([@bib56]; [@bib139]; [@bib155]). Although paper-based devices have historically been most commonly used with colorimetric sensing techniques, they have been increasingly investigated for electrochemical biosensing ([@bib5]; [@bib194]). A highlight of paper-based substrates is provided in [Fig. 7](#fig7){ref-type="fig"}c.

The need for water safety and medical diagnostics in remote and under-developed regions has led to the demand for low-cost portable biosensing platforms. One of the major challenges in creating portable biosensors for field use is the need to establish sample preparation-free protocols ([@bib128]) and miniaturize components for actuation, data acquisition, and readout. However, device miniaturization also presents measurement challenges, such as increasing the biosensor signal-to-noise ratio ([@bib299]). Further, portable biosensing platforms should exhibit biorecognition elements that remain stable for extended periods and at a variety of temperatures and humidity levels. The measurement robustness associated with the analysis of small sample volumes also requires further attention with the use of emerging low-cost materials, fabrication approaches, and transduction methods ([@bib145]; [@bib178]; [@bib201]; [@bib290]).

The elimination of sample preparation steps from biosensor-based assays represents a significant advantage relative to traditional bioanalytical techniques ([@bib128]) and is an important advantage and consideration for single-use biosensors and remote biosensing applications based on portable low-cost platforms. Sample preparation-free protocols can improve measurement confidence, repeatability, and reduce TTR, which are important aspects of healthcare decision-making. For example, it has been shown that a reduction in turnaround time for diagnostic assays could have a positive effect on clinical treatment outcomes ([@bib63]; [@bib258]). When sample preparation is required, integrated alternatives to manual techniques, such as microfluidic processes, may provide a new path toward achieving rapid and robust pathogen detection. For example, separation and pre-concentration steps have been increasingly examined for integration with microfluidic-based biosensor platforms to reduce the number of steps, materials needed, and required technical personnel, and thus TTR ([@bib32]).

5.7. Wireless transduction approaches {#sec5.7}
-------------------------------------

The examination of wireless transduction and monitoring approaches has an important role in creating portable and wearable biosensing platforms for pathogen detection and distributed sensing systems for infection control and process monitoring ([@bib89]). Wireless biosensing platforms are also essential to the creation of implantable and integrated biosensors for pathogen detection, including those for medical diagnostics. For example, as previously referenced, Mannoor et al. fabricated a conformal biosensor for bacteria detection on tooth enamel based on a radiofrequency (RF) link approach ([@bib185]) (see [Fig. 7](#fig7){ref-type="fig"}d). Wireless transduction approaches remains an emerging area for pathogen detection. An example of smartphone-enabled wireless signal processing for detection of *E. coli* can be found in [Fig. 7](#fig7){ref-type="fig"}e ([@bib127]).

6. Conclusions {#sec6}
==============

Here, we provided a critical review of electrochemical biosensors for pathogen detection. Biosensor transduction elements and biorecognition elements for electrochemical pathogen detection were reviewed. Bacteria remain the most commonly detected pathogens using electrochemical biosensors, though the detection of viruses and protozoa have been increasingly examined over the past five years. Electrochemical biosensors now exhibit LODs as low as a single plaque-forming unit (PFU)/mL and colony-forming unit (CFU)/mL and dynamic ranges that span multiple orders of magnitude. While planar Au electrodes remain the most commonly utilized working electrode, nanostructured electrodes derived from a variety of engineering materials, including polymers and composites, have been increasingly examined. Present challenges and future directions in the field were discussed, including a need for further low-cost, reusable, and wearable biosensors. Electrochemical biosensors offer great potential as resources for improving global healthcare, such as preventing the spread of highly contagious diseases.
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